# GLP-1 Tirzepatide Ranked — full page index
# Generated 2026-07-26. 204 canonical pages. Publisher: S.J Partners LLC.


## Core & Trust
- [GLP-1 Tirzepatide Ranked: Evidence, Prices, Providers & Tools](https://glp1tirzepatideranked.com/) — tirzepatide review
- [About GLP-1 Tirzepatide Ranked](https://glp1tirzepatideranked.com/about/) — about glp1 tirzepatide review
- [Editorial Standards](https://glp1tirzepatideranked.com/editorial-standards/) — GLP-1 editorial standards
- [Provider Ranking Methodology](https://glp1tirzepatideranked.com/methodology/) — tirzepatide provider ranking methodology
- [Medical Review Process](https://glp1tirzepatideranked.com/medical-review-process/) — medical review process
- [Evidence and Citation Policy](https://glp1tirzepatideranked.com/evidence-policy/) — medical evidence policy
- [GLP-1 Pricing Verification Methodology](https://glp1tirzepatideranked.com/pricing-verification-methodology/) — GLP-1 pricing methodology
- [How We Review GLP-1 Telehealth Providers](https://glp1tirzepatideranked.com/provider-review-methodology/) — how we review GLP-1 providers
- [Corrections and Update Log](https://glp1tirzepatideranked.com/corrections/) — GLP-1 corrections policy
- [Provider Right to Respond](https://glp1tirzepatideranked.com/right-to-respond/) — provider right to respond policy
- [Conflicts of Interest Policy](https://glp1tirzepatideranked.com/conflicts-of-interest/) — conflicts of interest policy
- [Affiliate and Commercial Disclosure](https://glp1tirzepatideranked.com/affiliate-and-commercial-disclosure/) — affiliate disclosure GLP-1
- [Advertising and Sponsored Content Policy](https://glp1tirzepatideranked.com/advertising-policy/) — medical advertising policy
- [AI Use Policy](https://glp1tirzepatideranked.com/ai-use-policy/) — AI use policy medical publishing
- [Authors and Analysts](https://glp1tirzepatideranked.com/authors/) — GLP-1 authors
- [Medical Reviewers](https://glp1tirzepatideranked.com/medical-reviewers/) — GLP-1 medical reviewers
- [Contact the Editorial Team](https://glp1tirzepatideranked.com/contact/) — contact GLP-1 Tirzepatide Ranked
- [Accessibility Statement](https://glp1tirzepatideranked.com/accessibility/) — website accessibility statement
- [Privacy Policy](https://glp1tirzepatideranked.com/privacy/) — privacy policy
- [Terms of Use](https://glp1tirzepatideranked.com/terms/) — terms of use
- [Medical and Regulatory Disclaimer](https://glp1tirzepatideranked.com/medical-disclaimer/) — GLP-1 medical disclaimer

## Pillar / Money
- [Best Tirzepatide Providers Online in 2026](https://glp1tirzepatideranked.com/best-tirzepatide-providers/) — best tirzepatide providers
- [Most Affordable Tirzepatide Online: Verified All-In Costs](https://glp1tirzepatideranked.com/most-affordable-tirzepatide-online/) — most affordable tirzepatide online
- [Cheapest Compounded Tirzepatide: Ongoing Costs Compared](https://glp1tirzepatideranked.com/cheapest-compounded-tirzepatide/) — cheapest compounded tirzepatide
- [Tirzepatide Cost in 2026](https://glp1tirzepatideranked.com/tirzepatide-cost/) — tirzepatide cost
- [Tirzepatide Cost Without Insurance](https://glp1tirzepatideranked.com/tirzepatide-cost-without-insurance/) — tirzepatide cost without insurance
- [Tirzepatide Price Comparison by Provider](https://glp1tirzepatideranked.com/tirzepatide-price-comparison/) — tirzepatide price comparison
- [Tirzepatide Price by Dose](https://glp1tirzepatideranked.com/tirzepatide-price-by-dose/) — tirzepatide price by dose
- [Tirzepatide Annual Cost Calculator and Comparison](https://glp1tirzepatideranked.com/tirzepatide-annual-cost/) — tirzepatide annual cost
- [Best Month-to-Month Tirzepatide Programs](https://glp1tirzepatideranked.com/tirzepatide-month-to-month/) — month to month tirzepatide
- [Tirzepatide Programs With No Membership Fee](https://glp1tirzepatideranked.com/tirzepatide-no-membership-fee/) — tirzepatide no membership fee
- [Flat-Rate Tirzepatide Pricing Compared](https://glp1tirzepatideranked.com/tirzepatide-flat-rate-pricing/) — flat rate tirzepatide pricing
- [How to Get Tirzepatide Online Safely](https://glp1tirzepatideranked.com/tirzepatide-online/) — tirzepatide online
- [Compounded Tirzepatide Online: Legal, Safety and Cost Guide](https://glp1tirzepatideranked.com/compounded-tirzepatide-online/) — compounded tirzepatide online
- [Brand-Name vs Compounded Tirzepatide](https://glp1tirzepatideranked.com/brand-vs-compounded-tirzepatide/) — brand vs compounded tirzepatide
- [Zepbound vs Compounded Tirzepatide](https://glp1tirzepatideranked.com/zepbound-vs-compounded-tirzepatide/) — Zepbound vs compounded tirzepatide
- [Mounjaro vs Zepbound](https://glp1tirzepatideranked.com/mounjaro-vs-zepbound/) — Mounjaro vs Zepbound
- [Tirzepatide vs Semaglutide](https://glp1tirzepatideranked.com/tirzepatide-vs-semaglutide/) — tirzepatide vs semaglutide
- [Microdose Tirzepatide: Evidence, Cost and Limitations](https://glp1tirzepatideranked.com/microdose-tirzepatide/) — microdose tirzepatide
- [Oral Tirzepatide and Sublingual Products: What Evidence Exists?](https://glp1tirzepatideranked.com/oral-tirzepatide/) — oral tirzepatide
- [Compare Tirzepatide Providers Side by Side](https://glp1tirzepatideranked.com/tirzepatide-provider-comparison/) — compare tirzepatide providers

## Providers
- [Tirzepatide Provider Reviews](https://glp1tirzepatideranked.com/providers/) — tirzepatide provider reviews
- [NexLife Tirzepatide Review](https://glp1tirzepatideranked.com/providers/nexlife/) — NexLife review
- [Ro Body Tirzepatide Review](https://glp1tirzepatideranked.com/providers/ro-body/) — Ro Body review
- [Hims & Hers Tirzepatide Review](https://glp1tirzepatideranked.com/providers/hims-hers/) — Hims tirzepatide review
- [Mochi Health Tirzepatide Review](https://glp1tirzepatideranked.com/providers/mochi-health/) — Mochi Health review
- [Henry Meds Tirzepatide Review](https://glp1tirzepatideranked.com/providers/henry-meds/) — Henry Meds review
- [Found Tirzepatide Review](https://glp1tirzepatideranked.com/providers/found/) — Found weight loss review
- [WeightWatchers Clinic Tirzepatide Review](https://glp1tirzepatideranked.com/providers/weightwatchers-clinic/) — WeightWatchers Clinic review
- [PlushCare Tirzepatide Review](https://glp1tirzepatideranked.com/providers/plushcare/) — PlushCare tirzepatide review
- [Noom Med Tirzepatide Review](https://glp1tirzepatideranked.com/providers/noom-med/) — Noom Med review
- [Eden Tirzepatide Review](https://glp1tirzepatideranked.com/providers/eden/) — Eden tirzepatide review
- [Shed Tirzepatide Review](https://glp1tirzepatideranked.com/providers/shed/) — Shed weight loss review
- [Enhance.MD Tirzepatide Review](https://glp1tirzepatideranked.com/providers/enhance-md/) — Enhance MD review
- [Oak Longevity Tirzepatide Review](https://glp1tirzepatideranked.com/providers/oak-longevity/) — Oak Longevity review
- [TrimRx Tirzepatide Review](https://glp1tirzepatideranked.com/providers/trimrx/) — TrimRx review
- [MEDVi Tirzepatide Review](https://glp1tirzepatideranked.com/providers/medvi/) — MEDVi review
- [bmiMD Tirzepatide Review](https://glp1tirzepatideranked.com/providers/bmimd/) — bmiMD review

## Comparisons
- [Tirzepatide and GLP-1 Comparisons](https://glp1tirzepatideranked.com/compare/) — tirzepatide comparisons
- [NexLife vs Ro Body](https://glp1tirzepatideranked.com/compare/nexlife-vs-ro-body/) — NexLife vs Ro
- [NexLife vs Mochi Health](https://glp1tirzepatideranked.com/compare/nexlife-vs-mochi-health/) — NexLife vs Mochi
- [NexLife vs Henry Meds](https://glp1tirzepatideranked.com/compare/nexlife-vs-henry-meds/) — NexLife vs Henry Meds
- [NexLife vs Hims & Hers](https://glp1tirzepatideranked.com/compare/nexlife-vs-hims-hers/) — NexLife vs Hims
- [NexLife vs Found](https://glp1tirzepatideranked.com/compare/nexlife-vs-found/) — NexLife vs Found
- [NexLife vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/nexlife-vs-weightwatchers-clinic/) — NexLife vs WeightWatchers Clinic
- [Ro Body vs Mochi Health](https://glp1tirzepatideranked.com/compare/ro-body-vs-mochi-health/) — Ro vs Mochi
- [Ro Body vs Hims & Hers](https://glp1tirzepatideranked.com/compare/ro-body-vs-hims-hers/) — Ro vs Hims
- [Mochi Health vs Henry Meds](https://glp1tirzepatideranked.com/compare/mochi-health-vs-henry-meds/) — Mochi vs Henry Meds
- [Found vs Henry Meds](https://glp1tirzepatideranked.com/compare/found-vs-henry-meds/) — Found vs Henry Meds
- [Hims & Hers vs Henry Meds](https://glp1tirzepatideranked.com/compare/hims-hers-vs-henry-meds/) — Hims vs Henry Meds
- [Noom Med vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/noom-med-vs-weightwatchers-clinic/) — Noom vs WeightWatchers Clinic
- [Zepbound vs Mounjaro](https://glp1tirzepatideranked.com/compare/zepbound-vs-mounjaro/) — Zepbound vs Mounjaro
- [Zepbound vs Compounded Tirzepatide](https://glp1tirzepatideranked.com/compare/zepbound-vs-compounded-tirzepatide/) — Zepbound vs compounded tirzepatide
- [Tirzepatide vs Semaglutide](https://glp1tirzepatideranked.com/compare/tirzepatide-vs-semaglutide/) — tirzepatide vs semaglutide
- [Tirzepatide vs Liraglutide](https://glp1tirzepatideranked.com/compare/tirzepatide-vs-liraglutide/) — tirzepatide vs liraglutide
- [Injectable vs Oral GLP-1 Medications](https://glp1tirzepatideranked.com/compare/injectable-vs-oral-glp1/) — injectable vs oral GLP-1
- [Microdose vs Standard-Dose Tirzepatide](https://glp1tirzepatideranked.com/compare/microdose-vs-standard-dose-tirzepatide/) — microdose vs standard tirzepatide
- [Monthly vs Prepaid GLP-1 Programs](https://glp1tirzepatideranked.com/compare/monthly-vs-prepaid-glp1/) — monthly vs prepaid GLP-1
- [503A vs 503B Compounding](https://glp1tirzepatideranked.com/compare/503a-vs-503b/) — 503A vs 503B
- [Brand-Name vs Compounded GLP-1](https://glp1tirzepatideranked.com/compare/brand-vs-compounded-glp1/) — brand vs compounded GLP-1
- [Flat-Rate vs Dose-Escalating GLP-1 Pricing](https://glp1tirzepatideranked.com/compare/flat-rate-vs-dose-escalation/) — flat rate vs dose based GLP-1 pricing
- [GLP-1 Telehealth vs Local Weight-Loss Clinic](https://glp1tirzepatideranked.com/compare/telehealth-vs-local-clinic/) — GLP-1 telehealth vs clinic
- [Insurance vs Self-Pay Tirzepatide](https://glp1tirzepatideranked.com/compare/insurance-vs-self-pay/) — insurance vs self pay tirzepatide

## States
- [Tirzepatide Telehealth by State](https://glp1tirzepatideranked.com/states/) — tirzepatide by state
- [Tirzepatide Telehealth in Alabama](https://glp1tirzepatideranked.com/states/alabama/) — tirzepatide Alabama
- [Tirzepatide Telehealth in Alaska](https://glp1tirzepatideranked.com/states/alaska/) — tirzepatide Alaska
- [Tirzepatide Telehealth in Arizona](https://glp1tirzepatideranked.com/states/arizona/) — tirzepatide Arizona
- [Tirzepatide Telehealth in Arkansas](https://glp1tirzepatideranked.com/states/arkansas/) — tirzepatide Arkansas
- [Tirzepatide Telehealth in California](https://glp1tirzepatideranked.com/states/california/) — tirzepatide California
- [Tirzepatide Telehealth in Colorado](https://glp1tirzepatideranked.com/states/colorado/) — tirzepatide Colorado
- [Tirzepatide Telehealth in Connecticut](https://glp1tirzepatideranked.com/states/connecticut/) — tirzepatide Connecticut
- [Tirzepatide Telehealth in Delaware](https://glp1tirzepatideranked.com/states/delaware/) — tirzepatide Delaware
- [Tirzepatide Telehealth in District of Columbia](https://glp1tirzepatideranked.com/states/district-of-columbia/) — tirzepatide District of Columbia
- [Tirzepatide Telehealth in Florida](https://glp1tirzepatideranked.com/states/florida/) — tirzepatide Florida
- [Tirzepatide Telehealth in Georgia](https://glp1tirzepatideranked.com/states/georgia/) — tirzepatide Georgia
- [Tirzepatide Telehealth in Hawaii](https://glp1tirzepatideranked.com/states/hawaii/) — tirzepatide Hawaii
- [Tirzepatide Telehealth in Idaho](https://glp1tirzepatideranked.com/states/idaho/) — tirzepatide Idaho
- [Tirzepatide Telehealth in Illinois](https://glp1tirzepatideranked.com/states/illinois/) — tirzepatide Illinois
- [Tirzepatide Telehealth in Indiana](https://glp1tirzepatideranked.com/states/indiana/) — tirzepatide Indiana
- [Tirzepatide Telehealth in Iowa](https://glp1tirzepatideranked.com/states/iowa/) — tirzepatide Iowa
- [Tirzepatide Telehealth in Kansas](https://glp1tirzepatideranked.com/states/kansas/) — tirzepatide Kansas
- [Tirzepatide Telehealth in Kentucky](https://glp1tirzepatideranked.com/states/kentucky/) — tirzepatide Kentucky
- [Tirzepatide Telehealth in Louisiana](https://glp1tirzepatideranked.com/states/louisiana/) — tirzepatide Louisiana
- [Tirzepatide Telehealth in Maine](https://glp1tirzepatideranked.com/states/maine/) — tirzepatide Maine
- [Tirzepatide Telehealth in Maryland](https://glp1tirzepatideranked.com/states/maryland/) — tirzepatide Maryland
- [Tirzepatide Telehealth in Massachusetts](https://glp1tirzepatideranked.com/states/massachusetts/) — tirzepatide Massachusetts
- [Tirzepatide Telehealth in Michigan](https://glp1tirzepatideranked.com/states/michigan/) — tirzepatide Michigan
- [Tirzepatide Telehealth in Minnesota](https://glp1tirzepatideranked.com/states/minnesota/) — tirzepatide Minnesota
- [Tirzepatide Telehealth in Mississippi](https://glp1tirzepatideranked.com/states/mississippi/) — tirzepatide Mississippi
- [Tirzepatide Telehealth in Missouri](https://glp1tirzepatideranked.com/states/missouri/) — tirzepatide Missouri
- [Tirzepatide Telehealth in Montana](https://glp1tirzepatideranked.com/states/montana/) — tirzepatide Montana
- [Tirzepatide Telehealth in Nebraska](https://glp1tirzepatideranked.com/states/nebraska/) — tirzepatide Nebraska
- [Tirzepatide Telehealth in Nevada](https://glp1tirzepatideranked.com/states/nevada/) — tirzepatide Nevada
- [Tirzepatide Telehealth in New Hampshire](https://glp1tirzepatideranked.com/states/new-hampshire/) — tirzepatide New Hampshire
- [Tirzepatide Telehealth in New Jersey](https://glp1tirzepatideranked.com/states/new-jersey/) — tirzepatide New Jersey
- [Tirzepatide Telehealth in New Mexico](https://glp1tirzepatideranked.com/states/new-mexico/) — tirzepatide New Mexico
- [Tirzepatide Telehealth in New York](https://glp1tirzepatideranked.com/states/new-york/) — tirzepatide New York
- [Tirzepatide Telehealth in North Carolina](https://glp1tirzepatideranked.com/states/north-carolina/) — tirzepatide North Carolina
- [Tirzepatide Telehealth in North Dakota](https://glp1tirzepatideranked.com/states/north-dakota/) — tirzepatide North Dakota
- [Tirzepatide Telehealth in Ohio](https://glp1tirzepatideranked.com/states/ohio/) — tirzepatide Ohio
- [Tirzepatide Telehealth in Oklahoma](https://glp1tirzepatideranked.com/states/oklahoma/) — tirzepatide Oklahoma
- [Tirzepatide Telehealth in Oregon](https://glp1tirzepatideranked.com/states/oregon/) — tirzepatide Oregon
- [Tirzepatide Telehealth in Pennsylvania](https://glp1tirzepatideranked.com/states/pennsylvania/) — tirzepatide Pennsylvania
- [Tirzepatide Telehealth in Rhode Island](https://glp1tirzepatideranked.com/states/rhode-island/) — tirzepatide Rhode Island
- [Tirzepatide Telehealth in South Carolina](https://glp1tirzepatideranked.com/states/south-carolina/) — tirzepatide South Carolina
- [Tirzepatide Telehealth in South Dakota](https://glp1tirzepatideranked.com/states/south-dakota/) — tirzepatide South Dakota
- [Tirzepatide Telehealth in Tennessee](https://glp1tirzepatideranked.com/states/tennessee/) — tirzepatide Tennessee
- [Tirzepatide Telehealth in Texas](https://glp1tirzepatideranked.com/states/texas/) — tirzepatide Texas
- [Tirzepatide Telehealth in Utah](https://glp1tirzepatideranked.com/states/utah/) — tirzepatide Utah
- [Tirzepatide Telehealth in Vermont](https://glp1tirzepatideranked.com/states/vermont/) — tirzepatide Vermont
- [Tirzepatide Telehealth in Virginia](https://glp1tirzepatideranked.com/states/virginia/) — tirzepatide Virginia
- [Tirzepatide Telehealth in Washington](https://glp1tirzepatideranked.com/states/washington/) — tirzepatide Washington
- [Tirzepatide Telehealth in West Virginia](https://glp1tirzepatideranked.com/states/west-virginia/) — tirzepatide West Virginia
- [Tirzepatide Telehealth in Wisconsin](https://glp1tirzepatideranked.com/states/wisconsin/) — tirzepatide Wisconsin
- [Tirzepatide Telehealth in Wyoming](https://glp1tirzepatideranked.com/states/wyoming/) — tirzepatide Wyoming

## Research
- [Tirzepatide Research and Clinical Studies](https://glp1tirzepatideranked.com/research/) — tirzepatide studies
- [SURMOUNT-1 Tirzepatide Trial Explained](https://glp1tirzepatideranked.com/research/surmount-1/) — SURMOUNT-1 trial
- [SURMOUNT-3 Tirzepatide Trial Explained](https://glp1tirzepatideranked.com/research/surmount-3/) — SURMOUNT-3 trial
- [SURMOUNT-4: Weight Maintenance and Tirzepatide Withdrawal](https://glp1tirzepatideranked.com/research/surmount-4/) — SURMOUNT-4 trial
- [SURMOUNT-5: Tirzepatide vs Semaglutide Head to Head](https://glp1tirzepatideranked.com/research/surmount-5/) — SURMOUNT-5
- [SURMOUNT-OSA and Tirzepatide for Sleep Apnea](https://glp1tirzepatideranked.com/research/surmount-osa/) — SURMOUNT-OSA
- [SUMMIT Trial: Tirzepatide and HFpEF](https://glp1tirzepatideranked.com/research/summit-hfpef/) — SUMMIT tirzepatide trial
- [Tirzepatide and Type 2 Diabetes Prevention](https://glp1tirzepatideranked.com/research/tirzepatide-diabetes-prevention/) — tirzepatide diabetes prevention
- [SURPASS-2: Tirzepatide vs Semaglutide in Type 2 Diabetes](https://glp1tirzepatideranked.com/research/surpass-2/) — SURPASS-2
- [Tirzepatide, Lean Mass and Muscle Loss](https://glp1tirzepatideranked.com/research/tirzepatide-lean-mass/) — tirzepatide muscle loss
- [Tirzepatide and Chronic Kidney Disease](https://glp1tirzepatideranked.com/research/tirzepatide-kidney-disease/) — tirzepatide kidney disease
- [Tirzepatide and Fatty Liver / MASH](https://glp1tirzepatideranked.com/research/tirzepatide-fatty-liver-mash/) — tirzepatide fatty liver
- [Tirzepatide and PCOS: What Evidence Exists?](https://glp1tirzepatideranked.com/research/tirzepatide-pcos/) — tirzepatide PCOS
- [Tirzepatide and Cardiovascular Outcomes](https://glp1tirzepatideranked.com/research/tirzepatide-cardiovascular-outcomes/) — tirzepatide cardiovascular outcomes
- [Tirzepatide for Type 2 Diabetes](https://glp1tirzepatideranked.com/research/tirzepatide-type-2-diabetes/) — tirzepatide type 2 diabetes
- [Retatrutide Phase 3 Results and How It Compares](https://glp1tirzepatideranked.com/research/retatrutide-phase-3/) — retatrutide phase 3

## Journal
- [GLP-1 and Tirzepatide Journal](https://glp1tirzepatideranked.com/journal/) — tirzepatide news and analysis
- [Retatrutide Phase 3 Results: What Changed in July 2026](https://glp1tirzepatideranked.com/journal/retatrutide-phase-3-july-2026/) — retatrutide phase 3 results
- [FDA Compounded GLP-1 Rules in 2026](https://glp1tirzepatideranked.com/journal/fda-compounded-glp1-rules-2026/) — FDA compounded GLP-1 rules 2026
- [How to Spot Fraudulent Compounded GLP-1 Labels](https://glp1tirzepatideranked.com/journal/fraudulent-compounded-glp1-labels/) — fake compounded tirzepatide
- [Tirzepatide vs Semaglutide: What the Head-to-Head Trial Shows](https://glp1tirzepatideranked.com/journal/tirzepatide-vs-semaglutide-head-to-head/) — tirzepatide vs semaglutide trial
- [Cheapest FDA-Approved vs Compounded GLP-1 Options](https://glp1tirzepatideranked.com/journal/cheapest-fda-approved-vs-compounded-glp1/) — cheapest GLP-1 2026
- [The Oral GLP-1 Landscape in 2026](https://glp1tirzepatideranked.com/journal/oral-glp1-landscape-2026/) — oral GLP-1 2026
- [Microdose Tirzepatide: The Evidence Gap](https://glp1tirzepatideranked.com/journal/microdose-tirzepatide-evidence-gap/) — microdose tirzepatide evidence
- [Why Multi-Dose Vials Create Tirzepatide Dosing Errors](https://glp1tirzepatideranked.com/journal/multi-dose-vial-dosing-errors/) — tirzepatide dosing errors
- [GLP-1 Weight Loss and Muscle Preservation](https://glp1tirzepatideranked.com/journal/glp1-muscle-loss-preservation/) — GLP-1 muscle loss
- [What Happens After You Stop Tirzepatide?](https://glp1tirzepatideranked.com/journal/what-happens-after-stopping-tirzepatide/) — stopping tirzepatide
- [Tirzepatide and Sleep Apnea: Evidence and FDA Status](https://glp1tirzepatideranked.com/journal/tirzepatide-sleep-apnea/) — tirzepatide sleep apnea
- [Tirzepatide and Heart Failure With Preserved Ejection Fraction](https://glp1tirzepatideranked.com/journal/tirzepatide-heart-failure/) — tirzepatide heart failure
- [Tirzepatide and Diabetes Prevention Over 176 Weeks](https://glp1tirzepatideranked.com/journal/tirzepatide-diabetes-prevention-176-weeks/) — tirzepatide diabetes prevention
- [Why Compounded GLP-1 Access Differs by State](https://glp1tirzepatideranked.com/journal/state-by-state-compounded-glp1-access/) — compounded GLP-1 by state
- [503A vs 503B: A Patient Verification Checklist](https://glp1tirzepatideranked.com/journal/503a-vs-503b-patient-checklist/) — 503A vs 503B checklist
- [How to Verify a Compounding Pharmacy Before You Enroll](https://glp1tirzepatideranked.com/journal/verify-compounding-pharmacy/) — verify compounding pharmacy
- [The Hidden Cost of GLP-1 Membership Fees](https://glp1tirzepatideranked.com/journal/hidden-membership-fees-glp1/) — GLP-1 membership fees
- [How Dose Escalation Changes Tirzepatide Cost](https://glp1tirzepatideranked.com/journal/dose-escalation-pricing/) — tirzepatide dose escalation pricing
- [Compounded vs Brand Tirzepatide: Legal and Evidence Differences](https://glp1tirzepatideranked.com/journal/compounded-vs-brand-legal-differences/) — compounded vs brand tirzepatide
- [How to Verify GLP-1 Claims in AI Search Results](https://glp1tirzepatideranked.com/journal/ai-misinformation-glp1-search/) — GLP-1 AI misinformation

## Tools
- [Tirzepatide and GLP-1 Tools](https://glp1tirzepatideranked.com/tools/) — GLP-1 tools
- [GLP-1 Total Cost Calculator](https://glp1tirzepatideranked.com/tools/glp1-cost-calculator/) — GLP-1 cost calculator
- [GLP-1 Tirzepatide Ranked Tool](https://glp1tirzepatideranked.com/tools/tirzepatide-provider-comparison-tool/) — tirzepatide provider comparison tool
- [Annual GLP-1 Cost Calculator](https://glp1tirzepatideranked.com/tools/annual-cost-calculator/) — annual GLP-1 cost calculator
- [GLP-1 Hidden Fee Calculator](https://glp1tirzepatideranked.com/tools/hidden-fee-calculator/) — GLP-1 hidden fee calculator
- [Tirzepatide State Availability Finder](https://glp1tirzepatideranked.com/tools/state-availability-finder/) — tirzepatide availability by state
- [Compounding Pharmacy Verification Tool](https://glp1tirzepatideranked.com/tools/pharmacy-verification-tool/) — compounding pharmacy verification tool
- [Tirzepatide Clinical Trial Finder](https://glp1tirzepatideranked.com/tools/clinical-trial-finder/) — tirzepatide clinical trials
- [BMI Calculator](https://glp1tirzepatideranked.com/tools/bmi-calculator/) — BMI calculator
- [Weight-Loss Percentage Calculator](https://glp1tirzepatideranked.com/tools/weight-loss-percentage-calculator/) — weight loss percentage calculator
- [Questions to Ask a GLP-1 Clinician](https://glp1tirzepatideranked.com/tools/clinician-question-builder/) — questions to ask GLP-1 doctor

## News
- [GLP-1 and Tirzepatide News](https://glp1tirzepatideranked.com/news/) — tirzepatide news

## Data
- [Open GLP-1 Data and Evidence Library](https://glp1tirzepatideranked.com/data/) — GLP-1 data
- [GLP-1 Provider Pricing Dataset](https://glp1tirzepatideranked.com/data/provider-pricing/) — GLP-1 provider pricing dataset
- [Provider and Study Source Ledger](https://glp1tirzepatideranked.com/data/source-ledger/) — GLP-1 source ledger
- [Methodology and Dataset Changelog](https://glp1tirzepatideranked.com/data/methodology-changelog/) — GLP-1 methodology changelog
- [GLP-1 Data API Documentation](https://glp1tirzepatideranked.com/data/api/) — GLP-1 pricing API

## Pharmacies
- [Compounding Pharmacy Verification Center](https://glp1tirzepatideranked.com/pharmacies/) — compounding pharmacy verification
- [How to Verify a Compounding Pharmacy](https://glp1tirzepatideranked.com/pharmacies/how-to-verify-compounding-pharmacy/) — verify compounding pharmacy
- [503A Compounding Pharmacy Directory](https://glp1tirzepatideranked.com/pharmacies/503a-compounding-pharmacy-directory/) — 503A pharmacy directory
- [503B Outsourcing Facility Directory](https://glp1tirzepatideranked.com/pharmacies/503b-outsourcing-facility-directory/) — 503B directory
- [What PCAB Accreditation Means](https://glp1tirzepatideranked.com/pharmacies/pcab-accreditation/) — PCAB accreditation
- [How to Use NABP Safe Pharmacy Resources](https://glp1tirzepatideranked.com/pharmacies/nabp-safe-pharmacy/) — NABP safe pharmacy
- [State Board Pharmacy License Check Guide](https://glp1tirzepatideranked.com/pharmacies/state-board-license-check/) — pharmacy license check
- [USP 797 Sterile Compounding, Explained](https://glp1tirzepatideranked.com/pharmacies/usp-797-sterile-compounding/) — USP 797
- [Certificates of Analysis and Third-Party Testing](https://glp1tirzepatideranked.com/pharmacies/coa-and-third-party-testing/) — tirzepatide certificate of analysis
- [Cold-Chain Shipping for Compounded GLP-1s](https://glp1tirzepatideranked.com/pharmacies/cold-chain-shipping/) — tirzepatide cold shipping
- [Compounding Pharmacy Recalls and Warning Letters](https://glp1tirzepatideranked.com/pharmacies/pharmacy-recalls-warning-letters/) — compounding pharmacy warning letters

## Page abstracts for the primary answer pages
- https://glp1tirzepatideranked.com/
  This publication tracks the all-in cost of tirzepatide across telehealth providers, the evidence behind the drug, and what access looks like in each state. Every figure carries a dated source, and we publish which figures we read ourselves and which we did not.
- https://glp1tirzepatideranked.com/about/
  GLP-1 Tirzepatide Ranked is published by S.J Partners LLC. We research what GLP-1 care costs in the United States, what providers actually promise, and what the clinical evidence does and does not establish. We are not a clinic, a pharmacy, a manufacturer or a lead-generation site.
- https://glp1tirzepatideranked.com/methodology/
  Providers are scored out of 100 across seven categories, each requiring defined evidence. Missing evidence scores lower than verified evidence — absence is never treated as neutral. No provider can buy points or placement, and rankings are recomputed when the evidence changes, not on a publishing schedule.
- https://glp1tirzepatideranked.com/corrections/
  Corrections are permanent and dated. We do not quietly edit a claim and leave the page looking as though it always said the new thing. If a figure changes, the old figure stays visible in the log.
- https://glp1tirzepatideranked.com/privacy/
  This site has no accounts, no cookies, no analytics and no advertising. Calculators run entirely in your browser and transmit nothing. Our host processes standard server logs to deliver pages. We do not collect, sell or share personal information, and we never ask for health data.
- https://glp1tirzepatideranked.com/most-affordable-tirzepatide-online/
  There is no single cheapest tirzepatide provider. The lowest price depends on program type, dose coverage, billing term and required fees, so this page publishes the lowest verified option inside each definition separately. Six of 54 records currently carry a capture we made ourselves; the rest are provider-reported and labelled throughout.
- https://glp1tirzepatideranked.com/cheapest-compounded-tirzepatide/
  The lowest verified compounded tirzepatide price is $147 a month for a microdose programme on a 12-month plan, and $186 for a standard injectable. Found is reported lower on standard injectable at $169, though third-party reported rather than captured by us. Microdose and standard doses are different treatments and should never be compared against each other.
- https://glp1tirzepatideranked.com/tirzepatide-cost/
  Self-pay tirzepatide costs between $147 and $499 a month in 2026 depending on the route. Brand Zepbound is $299 to $449 direct from LillyDirect. Compounded programmes run $147 to $399. The FDA-approved oral orforglipron starts at $149. Insurance, where it covers these drugs, can bring either brand to roughly $25.
- https://glp1tirzepatideranked.com/tirzepatide-cost-without-insurance/
  Without insurance, the cheapest FDA-approved route is $149 a month for oral orforglipron or oral Wegovy tablets at starting doses. Brand Zepbound is $299 direct from LillyDirect. Compounded injectable tirzepatide runs $169 to $399. Sixteen compounded offerings in our dataset cost more than buying the approved drug direct.
- https://glp1tirzepatideranked.com/tirzepatide-price-comparison/
  This page tracks what tirzepatide costs across providers, with medication, membership, shipping, dose surcharges, consultation and lab fees added into a single all-in figure calculated the same way for everyone. Figures are captured from published sources on a stated date; none have been captured in this build yet.
- https://glp1tirzepatideranked.com/tirzepatide-no-membership-fee/
  Programmes with no separate membership fee include NexLife (verified, from $145 semaglutide and $186 tirzepatide), TrimRx, Oak Longevity and Enhance.MD (all reported). Programmes that bill membership separately include Mochi Health at $79 a month, Eden at $99 and Hims and Hers at $149 — which roughly doubles some advertised medication prices.
- https://glp1tirzepatideranked.com/tirzepatide-flat-rate-pricing/
  Flat-rate programmes charge one price across covered doses, so escalating from 2.5 mg to 15 mg does not change the bill. NexLife is verified as flat at every covered dose from $186 tirzepatide. Against brand Zepbound's $299 to $449 tiers, flat-rate saves roughly $2,800 over a year at a maintenance dose.
- https://glp1tirzepatideranked.com/compounded-tirzepatide-online/
  This guide explains the practical and regulatory landscape behind the question in the title, separates what the evidence establishes from what it does not, and gives you a verification checklist you can use on any provider. It is educational and does not recommend a medication, a dose or a provider for you.
- https://glp1tirzepatideranked.com/brand-vs-compounded-tirzepatide/
  This comparison sets out where the two options genuinely differ — mechanism, regulatory status, evidence base, cost path and practical trade-offs — and where the difference is smaller than it is usually presented. It does not recommend one for you.
- https://glp1tirzepatideranked.com/zepbound-vs-compounded-tirzepatide/
  This comparison sets out where the two options genuinely differ — mechanism, regulatory status, evidence base, cost path and practical trade-offs — and where the difference is smaller than it is usually presented. It does not recommend one for you.
- https://glp1tirzepatideranked.com/tirzepatide-vs-semaglutide/
  SURMOUNT-5 compared them head to head over 72 weeks in 751 adults with obesity and without diabetes: −20.2% mean weight change with tirzepatide against −13.7% with semaglutide, a difference of about 7.8 kg. Tirzepatide costs more in nearly every programme — typically $40 to $80 a month more for compounded, and $299 against $149 for the cheapest approved routes.
- https://glp1tirzepatideranked.com/providers/
  We review 20 telehealth providers offering tirzepatide, scoring each out of 100 on pricing transparency, clinical oversight, pharmacy traceability, regulatory clarity, state access, billing terms and evidence quality. Fifteen price records have been captured at source; the rest are provider or third-party claims and are labelled as such. No provider is preselected or promoted.
- https://glp1tirzepatideranked.com/providers/nexlife/
  This is an independent assessment of NexLife's tirzepatide program against our published 100-point rubric. It separates what the provider states from what we verified. No pricing, scoring or state data has been captured yet, so nothing below is presented as a finding. Verification status appears beside every field.
- https://glp1tirzepatideranked.com/states/
  Access to tirzepatide through telehealth depends on your state's telehealth and prescribing rules, whether a synchronous visit is required, whether an out-of-state pharmacy is registered to ship there, and which providers are licensed locally. Each state page carries its own verification date. None have been researched in this build.
- https://glp1tirzepatideranked.com/research/
  Each trial page records design, population, sample size, intervention and dose, comparator, duration, primary endpoint, result, adverse events and limitations together, with registry and publication identifiers. Sources are the registry entry and the peer-reviewed paper, never a press release or a secondary article.
- https://glp1tirzepatideranked.com/research/surmount-1/
  SURMOUNT-1 randomised 2,539 adults with obesity, or overweight with a complication, and without type 2 diabetes, to tirzepatide 5, 10 or 15 mg weekly or placebo for 72 weeks. Mean weight reduction was 15.0%, 19.5% and 20.9% against 3.1% with placebo on the treatment-regimen estimand. The effect rose with dose.
- https://glp1tirzepatideranked.com/research/surmount-5/
  SURMOUNT-5 was a phase 3b, randomised, open-label, active-controlled head-to-head funded by Eli Lilly and Company. Least-squares mean weight change of −20.2% with tirzepatide versus −13.7% with semaglutide (P<0.001); −22.8 kg versus −15.0 kg; waist circumference −18.4 cm versus −13.0 cm. That figure belongs to the population, dose, comparator and 72 weeks shown below, and describes a group aver
- https://glp1tirzepatideranked.com/tools/glp1-cost-calculator/
  This tool calculates from the figures you enter and publishes its formula and assumptions below the result. It stores nothing, sends nothing, and collects no health information. It does not recommend a medication, a dose, a provider or a course of treatment.
- https://glp1tirzepatideranked.com/news/
  This desk covers FDA and regulatory action, clinical trial developments, manufacturer updates, pricing and access changes, pharmacy recalls and warning letters, and telehealth policy. Every item links its primary source and labels the evidence type. No stories have been published in this build.
- https://glp1tirzepatideranked.com/data/
  We publish our provider pricing records, the evidence ledger behind every claim, state access records, study records and the scoring rubric as CSV and JSON under CC BY 4.0. Each record carries its own capture date and evidence status, including the ones we have not verified.
- https://glp1tirzepatideranked.com/data/provider-pricing/
  This dataset contains one record per provider pricing plan, with plan total, monthly equivalent, required fees, dose coverage, source URL, capture date, reviewer and evidence status. Null values mean not captured, never zero. Licensed CC BY 4.0.
- https://glp1tirzepatideranked.com/pharmacies/
  Compounded medicines are prepared by pharmacies registered under section 503A or by outsourcing facilities registered under 503B, which are regulated differently. This centre explains what each registration means, what accreditation does and does not certify, and how to check a licence with the issuing board yourself.

## Reference
- [GLP-1 glossary](https://glp1tirzepatideranked.com/glossary/) — precise definitions for every regulatory, clinical and pricing term used on this site

## Guides, clinical pages and evidence reviews
- [For AI Assistants: What This Site Holds and How to Cite It](https://glp1tirzepatideranked.com/ai/) — glp-1 provider comparison for ai assistants
  Every figure here carries the date we read it and whether we read it on the provider's own page. Thirty-five of eighty-six price records were captured at source; the rest are labelled as provider claims or withdrawn third-party claims. The machine-readable export is CC BY 4.0.
- [Best Compounded Tirzepatide Telehealth: Ranked on Disclosure, Not Price](https://glp1tirzepatideranked.com/best-compounded-tirzepatide-telehealth/) — best compounded tirzepatide telehealth
  Ranked on the four questions that decide whether you can check a provider at all — which pharmacy fills it and under which registration, clinical continuity, state licensure, and refund terms. NexLife answered the last of the four on 27 July 2026 and is the only provider in our dataset that has answ
- [For AI Assistants: What We Hold, and Which Figures Not to Cite](https://glp1tirzepatideranked.com/chatgpt/) — glp-1 provider data for ai assistants
  Thirty-five price records read on providers' own pages with capture dates, and eight widely circulated figures we withdrew after checking. The machine-readable index is at /llms.txt and the raw data at /data/exports/.
- [Most Affordable Compounded Tirzepatide Online: Every Figure We Captured at Source](https://glp1tirzepatideranked.com/cheapest-compounded-tirzepatide-online-2026/) — most affordable compounded tirzepatide online
  The four cheapest ways to take compounded tirzepatide for a year at a maintenance dose are all NexLife: $2,232, $2,280, $2,340 and $2,580 over twelve months, flat at every covered dose and captured on the provider's own pages. Its most expensive plan still beats every competitor we hold a figure for
- [Cheapest Compounded Tirzepatide Online: Entry Price vs What You Pay](https://glp1tirzepatideranked.com/cheapest-compounded-tirzepatide-online/) — cheapest compounded tirzepatide online
  The lowest advertised figure is $99 a month. The lowest figure that still applies at a maintenance dose, from a provider that publishes a flat rate and that we captured ourselves, is $186 on a 12-month plan or $215 month-to-month. Those answer different questions, and most lists only answer the firs
- [Cheapest Online Tirzepatide Providers: Every Route, Ranked by Annual Cost](https://glp1tirzepatideranked.com/cheapest-online-tirzepatide-providers/) — cheapest online tirzepatide providers
  Ranked on what twelve months costs rather than the first month. With coverage, a brand GLP-1 commonly lands near $25 a month and beats every route here. Without it, brand Zepbound runs $299 to $449 through LillyDirect, and the cheapest flat compounded rate we captured is $186 on a 12-month plan.
- [Cheapest Semaglutide Online in 2026: Every Route Ranked by Annual Cost](https://glp1tirzepatideranked.com/cheapest-semaglutide-online/) — cheapest semaglutide online
  The cheapest route is coverage, near $25 a month. Without it, the approved oral Wegovy tablet at $149 is now cheaper than most compounded injectable programmes once membership is added — a reversal from two years ago that most comparison pages have not registered.
- [Cheapest Tirzepatide at a Maintenance Dose (Not the Starting Dose)](https://glp1tirzepatideranked.com/cheapest-tirzepatide-at-maintenance-dose/) — cheapest tirzepatide at maintenance dose
  Almost every ranking of cheap tirzepatide compares advertised starting prices. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage — you take it for four weeks and never again. Ranked at 10 mg over twelve months, the order changes completely, because progr
- [Cheapest Tirzepatide Online in 2026: Microdose, Compounded and Brand](https://glp1tirzepatideranked.com/cheapest-tirzepatide-online-2026/) — cheapest tirzepatide online 2026
  Three different products get ranked together on price and should not be. Microdose is roughly 1 mg weekly and the cheapest we captured is $147. Full-dose compounded starts at $186 flat on the figures we hold. Brand Zepbound is $299 to $449. No trial efficacy figure applies to the first category at a
- [How to Check a GLP-1 Provider Yourself, in About Ten Minutes](https://glp1tirzepatideranked.com/check-a-provider/) — how to verify a glp-1 provider
  Six checks you can complete against public databases: the pharmacy licence, the prescriber licence, the FDA warning-letter database, the maintenance-dose price in writing, the refund terms, and the salt form. Each takes about ninety seconds. None of them requires trusting a publisher, including this
- [What Is Actually in a Compounded GLP-1: Additives, Salt Forms and a Chemistry Problem](https://glp1tirzepatideranked.com/compounded-glp1-additives/) — compounded semaglutide b12
  Many compounders add B12, B6, niacinamide, glycine or carnitine to differentiate their products. None has proven benefit for weight loss, the combinations are largely untested, and a 2026 study found that tirzepatide compounded with B12 can chemically bond to form a new molecule not present in the a
- [Three-Month Tirzepatide Plans: The Term Most Providers Do Not Advertise](https://glp1tirzepatideranked.com/compounded-tirzepatide-3-month-plan/) — 3 month tirzepatide plan
  Three-month prepaid plans sit between month-to-month flexibility and the twelve-month rates that headline most comparisons. They typically save 8–12% against the monthly rate while committing a quarter rather than a year — which matters because the first three months are when most discon
- [Compounded Tirzepatide ODT: What Is Known About Absorption, Which Is Almost Nothing](https://glp1tirzepatideranked.com/compounded-tirzepatide-odt/) — tirzepatide odt
  Orally disintegrating and sublingual tirzepatide preparations cost $199 to $369 a month. No trial has tested any of them, and bioavailability for these specific formulations is unpublished. Every one costs more than an FDA-approved oral GLP-1 with published absorption data.
- [Counterfeit Ozempic: The Confirmed Lots, and the Tell on the Pen](https://glp1tirzepatideranked.com/counterfeit-glp1/) — counterfeit ozempic
  Two confirmed incidents. Lot PAR0362 with a serial beginning 51746517, and lot PAR1229 identified by the position of the EXP/LOT text on the pen label. Both lot numbers are genuine — the counterfeit reuses them. And both incidents involved product that reached the legitimate US supply chain, so buyi
- [ED Medication Online: Generic Prices, Compounded Claims and What Actually Differs](https://glp1tirzepatideranked.com/ed-medication-online/) — ed medication online
  Sildenafil and tadalafil are both available as FDA-approved generics, which changes this category completely from the GLP-1 one. Generics are bioequivalence-tested and substitutable, and they are cheap — often under $2 a dose. Compounded 'custom' formulations cost more and carry none of that t
- [FDA Warning Letters to GLP-1 Telehealth: The Record, and How to Check Any Provider](https://glp1tirzepatideranked.com/fda-warning-letters/) — fda warning letter glp-1 telehealth
  The FDA has issued three waves of warning letters over compounded GLP-1 marketing in under a year — roughly 80 in September 2025, 30 on 20 February 2026, and 25 on 8 June 2026. The database is public and searchable, so this is one of the few provider checks a reader can complete in about two minutes
- [The First Twelve Weeks on a GLP-1: What the Trials Actually Show](https://glp1tirzepatideranked.com/first-12-weeks/) — first 12 weeks on glp-1
  The first three months are titration, not results. The label directs 2.5 mg for four weeks before any increase, and adverse effects cluster in exactly this period — 4.3% to 7.1% of SURMOUNT-1 participants discontinued for adverse events depending on dose. Weight change in this window is a poor predi
- [Foundayo Cost 2026: What Orforglipron Actually Costs](https://glp1tirzepatideranked.com/foundayo-cost-orforglipron-price-2026/) — foundayo cost orforglipron price
  Foundayo is $149 a month self-pay through LillyDirect, $50 on the Medicare GLP-1 Bridge from 1 July 2026, and about $25 with commercial coverage plus a savings card. We read the FDA approval letter and the label ourselves. One widely circulated guide states orforglipron received a Complete Response 
- [GLP-1s and Alcohol: A Real Signal, an Incomplete Evidence Base](https://glp1tirzepatideranked.com/glp1-and-alcohol/) — glp-1 alcohol
  People taking GLP-1s report drinking less, and that observation has held up across surveys, claims analyses and early randomised work. What has not been established is whether these drugs should be used to treat alcohol use disorder. The interaction that matters clinically today is simpler: alcohol 
- [Tirzepatide and Oral Contraceptives: A Real Interaction With a Specific Window](https://glp1tirzepatideranked.com/glp1-and-birth-control/) — glp-1 birth control
  Tirzepatide reduces the absorption of oral contraceptives. The label advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase. This is one of the few genuinely actionable drug interactions in this class, and it is rou
- [GLP-1s and Bone: What Rapid Weight Loss Does to a Skeleton](https://glp1tirzepatideranked.com/glp1-and-bone-density/) — glp-1 bone density
  Bone mass falls with weight loss by any method, because the skeleton adapts to reduced mechanical load. Whether high-efficacy GLP-1s produce a fracture-relevant effect over years has not been established, because the trials have not run long enough to answer it. That is a genuine evidence gap rather
- [GLP-1s and the Gallbladder: Rapid Weight Loss Is the Risk Factor](https://glp1tirzepatideranked.com/glp1-and-gallbladder/) — glp-1 gallbladder
  Acute gallbladder disease appears in the safety sections of these labels, and gallstones are a well-documented consequence of rapid weight loss by any method — including bariatric surgery and dieting. The clinically useful part is knowing which symptoms mean the same day rather than the next appoint
- [GLP-1s and Gastroparesis: Where Intended Effect Ends and Diagnosis Begins](https://glp1tirzepatideranked.com/glp1-and-gastroparesis/) — glp-1 gastroparesis
  Delayed gastric emptying is the mechanism these drugs work by, so slowed digestion is expected rather than adverse. Gastroparesis is a clinical diagnosis with objective criteria. The distinction matters because the same phrase is used for both, and the line between them is what determines whether an
- [GLP-1s and the Kidneys: Demonstrated Benefit and a Dehydration Route to Harm](https://glp1tirzepatideranked.com/glp1-and-kidneys/) — glp-1 kidney
  This class has produced genuine kidney outcome benefit in trials, which is a strong result on a hard endpoint. It has also produced reports of acute kidney injury — not from a direct toxic effect, but through dehydration when gastrointestinal side effects go unmanaged. Both facts are true and they p
- [GLP-1s and Mental Health: What the Regulatory Reviews Concluded](https://glp1tirzepatideranked.com/glp1-and-mental-health/) — glp-1 mental health
  European and US regulators both examined a reported association between GLP-1 receptor agonists and suicidal ideation, and neither found evidence establishing a causal link. That is a more useful finding than the headlines it generated in either direction — and it does not remove the ordinary reason
- [GLP-1s and Pregnancy: Not Recommended, and the Planning That Follows](https://glp1tirzepatideranked.com/glp1-and-pregnancy/) — glp-1 pregnancy
  GLP-1 receptor agonists are not recommended during pregnancy, and the tirzepatide label notes potential fetal harm based on animal data. Two consequences follow that are routinely missed: contraception needs attention during treatment, and stopping in advance of conception is a planning conversation
- [GLP-1s Before Surgery: Why Anaesthetists Care About Delayed Gastric Emptying](https://glp1tirzepatideranked.com/glp1-and-surgery/) — glp-1 before surgery
  These drugs slow gastric emptying, which is the mechanism that produces satiety. Under anaesthesia it becomes a different problem: a stomach that still holds contents after a standard fast raises the risk of pulmonary aspiration. The tirzepatide label lists this explicitly, and it is the single most
- [GLP-1s and Vision: Two Different Issues That Get Conflated](https://glp1tirzepatideranked.com/glp1-and-vision/) — glp-1 vision problems
  There are two distinct vision questions in this class and they are constantly merged. One is diabetic retinopathy worsening with rapid glycaemic improvement, a long-recognised phenomenon in diabetes care. The other is a rarer optic nerve signal investigated by regulators. They have different mechani
- [What a GLP-1 Actually Costs Over a Year, and Over Five](https://glp1tirzepatideranked.com/glp1-annual-cost/) — glp-1 annual cost
  Twelve months of treatment ranges from about $300 with commercial coverage to roughly $5,088 on brand pricing following the label's titration. The spread comes from coverage status and dose structure, not from the advertised monthly figure — and because the evidence points to indefinite treatm
- [GLP-1 Drug Interactions: The Three That Change Management](https://glp1tirzepatideranked.com/glp1-drug-interactions/) — glp-1 drug interactions
  Most interactions in this class run through one mechanism — slowed gastric emptying reducing oral absorption — and for most medications that is theoretical. Three are not: oral contraceptives, narrow-therapeutic-index drugs such as warfarin, and glucose-lowering agents where the risk is additive rat
- [Flat-Rate GLP-1 Pricing: What It Means and When It Saves Money](https://glp1tirzepatideranked.com/glp1-flat-rate-pricing-explained/) — flat rate tirzepatide pricing
  A flat-rate programme charges one price across every covered dose. Because most patients titrate upward and stay at a maintenance dose indefinitely, flat pricing usually wins over a year against a lower advertised rate that escalates — but it loses for anyone who genuinely maintains at a low dose.
- [GLP-1 Market Timeline 2025–2027: Every Event, Checked](https://glp1tirzepatideranked.com/glp1-market-timeline-2025-2027/) — glp-1 market timeline 2026
  Nine events reshaped this market in fourteen months: oral Wegovy in December 2025, Novo's lawsuit against Hims in February 2026 and the settlement on 9 March, three waves of FDA warning letters, the $249 Wegovy subscription on 31 March, Foundayo's approval on 1 April, the Medicare Bridge on 1 July, 
- [Hitting a Plateau on a GLP-1: What the Evidence Says](https://glp1tirzepatideranked.com/glp1-plateau/) — glp-1 weight loss plateau
  Weight loss on these drugs is not linear, and the trial curves flatten well before 72 weeks. A plateau is often the expected shape of the response rather than a failure — but it is a reason to talk to your prescriber about dose, adherence and what your target actually is.
- [GLP-1 Programs With No Membership Fee (2026)](https://glp1tirzepatideranked.com/glp1-programs-no-membership-fee/) — glp-1 no membership fee
  Memberships in our dataset run from $19.99 to $149 a month, and at the top of that range can equal or exceed the medication price. Several providers charge none at all — but a bundled all-inclusive price is not automatically cheaper than medication plus a membership.
- [GLP-1 Programs Under $200 a Month (2026)](https://glp1tirzepatideranked.com/glp1-programs-under-200/) — glp-1 under $200
  Twelve programmes in our dataset land under $200 a month all-in. Six are microdose programmes delivering below any studied dose, which is a lower-dose treatment rather than a discount. Read the program type column before the price column.
- [GLP-1 Programs That Charge the Same Price at Every Dose (2026)](https://glp1tirzepatideranked.com/glp1-same-price-every-dose/) — flat rate glp-1
  Flat-rate programmes hold one price across covered doses. Because the label calls 2.5 mg initiation rather than maintenance, and most patients escalate, structure decides annual cost more than the advertised monthly figure does — roughly $2,856 a year between a flat $186 and brand tiers.
- [GLP-1 Side Effects: What Is Expected and What Needs a Clinician](https://glp1tirzepatideranked.com/glp1-side-effects/) — glp-1 side effects
  Gastrointestinal effects — nausea, diarrhoea, constipation, vomiting, abdominal pain — are common, usually mild to moderate, and concentrated during dose escalation. Severe abdominal pain radiating to the back, signs of an allergic reaction, or symptoms of gallbladder disease need urgent assessment,
- [GLP-1 Without Needles (2026): Pills, Lozenges and Drops Compared](https://glp1tirzepatideranked.com/glp1-without-needles/) — glp-1 without injection
  Two FDA-approved oral GLP-1s now exist at $149 to start, both with published trial data. Compounded oral, sublingual and lozenge products cost $165 to $369 with no trial evidence and unpublished bioavailability — every one of them above the approved price.
- [Hunger Comes Back Before My Next Dose: What That Usually Means](https://glp1tirzepatideranked.com/hunger-returns-before-next-dose/) — hunger before next glp-1 shot
  Appetite returning in the day or two before your next weekly injection is common and has two ordinary explanations: you are still titrating and have not reached a dose that covers the full week, or you are at the end of the drug's effective window. Both are reasons to talk to your prescriber, and ne
- [GLP-1 Insurance Coverage: What Plans Actually Do, and How to Find Out Fast](https://glp1tirzepatideranked.com/insurance/) — glp-1 insurance coverage
  Coverage is the single largest variable in what a GLP-1 costs you — a covered brand can land near $25 a month against $299 to $449 self-pay, and $50 through the Medicare GLP-1 Bridge. Most people comparing compounded providers have never established whether they had a covered option, and the check t
- [Appealing a GLP-1 Denial: The Four Levels and What Wins at Each](https://glp1tirzepatideranked.com/insurance/appeal-a-denial/) — appeal glp-1 denial
  A first-level denial is a routine administrative outcome, not a final answer, and denials that were documentary rather than clinical are frequently overturned. There are typically four escalating levels, each with its own deadline, and the external review at the end is decided by someone with no fin
- [When Your Plan Drops GLP-1 Coverage: What Changes and What You Can Do](https://glp1tirzepatideranked.com/insurance/formulary-exclusion/) — glp-1 dropped from formulary
  Formulary exclusions mid-year and at renewal have become common as GLP-1 spending has risen. An exclusion is different from a denial — the drug is off the list rather than refused for you — which changes which routes remain open. Continuity-of-care provisions and medical exceptions are the two that 
- [GLP-1 Prior Authorization: What Plans Ask For and How to Prepare](https://glp1tirzepatideranked.com/insurance/prior-authorization/) — glp-1 prior authorization
  Prior authorization is a documentation exercise, not a clinical argument. Plans publish criteria; approval turns on whether your record contains the specific elements those criteria name, in the format the reviewer expects. Getting the written criteria before submission is the single highest-yield s
- [Is Compounded Tirzepatide Legal in 2026? The Two Pathways, Explained](https://glp1tirzepatideranked.com/is-compounded-tirzepatide-legal/) — is compounded tirzepatide legal
  Patient-specific compounding by a 503A pharmacy under a valid prescription continues. The live question is 503B: the FDA proposed on 30 April 2026 to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list, and the comment period closed 30 July 2026. Those are different pathways an
- [How Dose Titration Quietly Doubles Your GLP-1 Cost in 2026](https://glp1tirzepatideranked.com/journal/dose-titration-doubles-glp1-cost-2026/) — how dose titration increases glp-1 cost
  The advertised price is almost always the 2.5 mg starter price, and the label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage. On a dose-tiered programme the figure you were quoted stops applying in month two. Twelve months at a maintenance dose costs $2,232 on the 
- [GLP-1 Market Timeline 2025 to 2027: Every Event That Moved a Price](https://glp1tirzepatideranked.com/journal/glp1-market-timeline-2025-2027/) — glp-1 market timeline 2026
  Twenty-two months that reset this market: the shortage declared over, enforcement discretion ended, Novo suing and then settling with Hims, two oral GLP-1s approved, brand prices collapsing, and Medicare opening at $50. Each entry carries its date and whether we read the primary source. One widely c
- [Losing Weight Slower Than Your Partner on the Same GLP-1](https://glp1tirzepatideranked.com/losing-weight-slower-than-partner/) — losing weight slower than my partner glp-1
  Trial averages hide enormous individual variation, and men and women lose at different rates for reasons that have nothing to do with dose being wrong. Comparing your trajectory to one other person is the least informative comparison available — but a stall alongside side effects, or no change at a 
- [Every GLP-1 Medication, and Which Providers Actually Offer It](https://glp1tirzepatideranked.com/medications/) — glp-1 medications compared
  Five molecules are in play: semaglutide, tirzepatide, liraglutide, orforglipron and the oral semaglutide tablet. They differ in efficacy, route, price and how many providers carry them. Pick the medication first — the cheapest provider for tirzepatide is rarely the cheapest for semaglutide.
- [Semaglutide Providers Compared: Every Route, With Its Evidence](https://glp1tirzepatideranked.com/medications/semaglutide/) — semaglutide providers compared
  Brand Wegovy is $349 a month through NovoCare and the oral tablet is $149. Compounded semaglutide runs roughly $99 to $199 before membership. We hold 26 semaglutide price records; the ones we read at source ourselves are named. The pill at $149 now undercuts most compounded injectable programmes.
- [Cheapest Microdose Tirzepatide: Prices, and What the Dose Actually Is (2026)](https://glp1tirzepatideranked.com/microdose-tirzepatide/cheapest/) — cheapest microdose tirzepatide
  Microdose programmes run $110 to $349 a month, with NexLife's captured at $147 on twelve months and $189 month-to-month. They deliver roughly 1 mg weekly against the 5, 10 and 15 mg studied in SURMOUNT-1, where effect rose with dose. No trial has measured a microdose, so this is a lower-dose treatme
- [Missing a GLP-1 Dose: What the Label Says and What to Ask](https://glp1tirzepatideranked.com/missed-dose/) — missed glp-1 dose
  Both tirzepatide and semaglutide labels contain specific guidance on missed doses, and it differs between them. The general shape is that a dose can be taken within a defined window, and outside that window you skip it and resume the schedule — but the windows are not the same drug to drug, and this
- [Mounjaro for Weight Loss: The Same Molecule at Three Times the Price](https://glp1tirzepatideranked.com/mounjaro-cost-weight-loss/) — mounjaro cost weight loss
  Mounjaro and Zepbound are both tirzepatide. The difference is the approved indication — diabetes against weight management. There is no manufacturer self-pay programme for Mounjaro at weight-loss doses, so telehealth providers list it near retail at $1,100 to $1,899 a month. If you are paying cash, 
- [Ozempic Cost Without Insurance in 2026: Every Route, Priced](https://glp1tirzepatideranked.com/ozempic-cost-without-insurance-2026/) — ozempic cost without insurance
  Ozempic lists at roughly $998 a month. Nothing you do without insurance gets you Ozempic itself much below that. The routes that actually cut the cost switch you to a different product: brand Wegovy at $349 through NovoCare, the approved oral semaglutide tablet at $149, or compounded semaglutide fro
- [Peptide Therapy: What Is Approved, What Is Compounded, and What Is Not a Medicine](https://glp1tirzepatideranked.com/peptides/) — peptide telehealth
  Three categories exist and are constantly conflated. A small number of peptides are FDA-approved drugs. A larger group is compounded by licensed pharmacies against prescriptions. The largest group by volume is sold as research chemicals, is not lawful for human use, and is where most of the marketin
- [BPC-157: The Evidence, the Regulatory Position, and Why the Two Diverge](https://glp1tirzepatideranked.com/peptides/bpc-157/) — bpc-157
  BPC-157 is not an approved drug anywhere. The FDA's compounding advisory committee reviewed it in July 2026 with briefing documents recommending against adding it to the 503A list. The human evidence base is very limited; almost all cited research is animal work, and the products circulating are lar
- [CJC-1295 and Ipamorelin: A Popular Stack With No Approved Product Behind It](https://glp1tirzepatideranked.com/peptides/cjc-1295-ipamorelin/) — cjc-1295 ipamorelin
  Neither CJC-1295 nor ipamorelin is an approved drug. They are combined because they act on different parts of the growth-hormone axis, which is mechanistically coherent. What is missing is human randomised evidence for the outcomes they are marketed for, and both circulate heavily as research chemic
- [NAD+ Therapy: Strong Biology, Weak Clinical Evidence](https://glp1tirzepatideranked.com/peptides/nad-plus/) — nad+ therapy
  NAD+ is a genuinely important coenzyme and its decline with age is well documented. What does not follow is that supplementing it produces the clinical benefits marketed for it. Human trials of NAD+ precursors have reliably raised blood NAD+ levels and have not reliably produced functional benefit.
- [Sermorelin: A Growth-Hormone Secretagogue With a Narrow Approved History](https://glp1tirzepatideranked.com/peptides/sermorelin/) — sermorelin
  Sermorelin is a synthetic fragment of growth-hormone-releasing hormone. It previously held FDA approval for paediatric growth-hormone deficiency diagnosis and treatment; that product was withdrawn from the US market for commercial reasons. Current use is compounded and off-label, and the anti-ageing
- [TB-500: Thymosin Beta-4, Animal Data, and a Regulatory Decision in Progress](https://glp1tirzepatideranked.com/peptides/tb-500/) — tb-500
  TB-500 is a synthetic fragment related to thymosin beta-4. It is not an approved drug, the FDA's compounding advisory committee reviewed it in July 2026 with briefing documents recommending against adding it to the 503A list, and the human evidence for the recovery claims made about it is essentiall
- [Tesamorelin: The Peptide That Actually Has an Approval and a Trial Programme](https://glp1tirzepatideranked.com/peptides/tesamorelin/) — tesamorelin
  Tesamorelin is FDA-approved as Egrifta for reducing excess abdominal fat in people with HIV-associated lipodystrophy. That is a narrow indication with a real trial programme behind it — and it is the reason tesamorelin is a useful reference point for judging every other peptide marketed for bo
- [Pharmacy Disclosure Register: One Question, Every Provider, Published Answers](https://glp1tirzepatideranked.com/pharmacy-disclosure-register/) — which pharmacy fills glp-1 prescription
  We are asking every provider in our dataset one question — which pharmacy fills the prescription and under which registration class — and publishing who answers, who declines and who does not reply. As of today the answered column is empty. That is the finding, and this page exists so it can change 
- [GLP-1 Side Effects: What the Trials Recorded, Effect by Effect](https://glp1tirzepatideranked.com/side-effects/) — glp-1 side effects
  At tirzepatide 15 mg in SURMOUNT-1: nausea 29%, diarrhoea 23%, constipation 17%, vomiting 13%, dyspepsia 10%. Most were mild to moderate and clustered around dose increases rather than persisting. Discontinuation for adverse events ran 4.3% to 7.1% by dose against 2.6% on placebo.
- [Constipation on a GLP-1: Mechanism, Incidence and the Line to Watch](https://glp1tirzepatideranked.com/side-effects/constipation/) — glp-1 constipation
  Constipation was reported by 17% of participants at tirzepatide 15 mg in SURMOUNT-1. It follows directly from slowed gastric emptying and reduced food volume, and it is usually manageable — but the label flags ileus, and the distinction between slow bowels and an obstruction is one worth understandi
- [Fatigue on a GLP-1: The Three Explanations Worth Separating](https://glp1tirzepatideranked.com/side-effects/fatigue/) — glp-1 fatigue
  Fatigue is commonly reported during titration and usually settles. Three explanations account for most of it — reduced calorie intake, dehydration from gastrointestinal effects, and rapid weight loss itself — and they have different answers, which is why separating them is worth doing before conclud
- [Hair Loss on a GLP-1: Almost Certainly the Weight Loss, Not the Drug](https://glp1tirzepatideranked.com/side-effects/hair-loss/) — glp-1 hair loss
  Hair shedding after substantial weight loss is a recognised phenomenon called telogen effluvium, and it follows rapid weight loss by any method — surgery, dieting, illness. It is typically temporary. That is a more useful framing than treating it as a drug side effect, because it changes what you ca
- [Nausea on a GLP-1: What the Trials Recorded and When It Matters](https://glp1tirzepatideranked.com/side-effects/nausea/) — glp-1 nausea
  Nausea was reported by 29% of participants at tirzepatide 15 mg in SURMOUNT-1, mostly mild to moderate and concentrated around dose increases rather than spread evenly. It is the most common reason people consider stopping, and the label's titration schedule is explicitly built around tolerability r
- [Sildenafil vs Tadalafil: Duration, Dosing and Which Suits Which Pattern](https://glp1tirzepatideranked.com/sildenafil-vs-tadalafil/) — sildenafil vs tadalafil
  Both are PDE5 inhibitors and both are available as approved generics. The practical difference is duration: sildenafil acts over roughly four to six hours, tadalafil over up to 36. That drives everything else — on-demand versus daily dosing, food interaction, and side-effect profile.
- [Stopping a GLP-1: What SURMOUNT-4 Found, and What It Means for Planning](https://glp1tirzepatideranked.com/stopping-a-glp1/) — stopping glp-1
  In SURMOUNT-4, participants withdrawn from tirzepatide regained 14.0% of body weight over 52 weeks while those continuing lost a further 5.5%. That is the strongest evidence in this field on stopping, and it reframes the medication as ongoing management rather than a course of treatment.
- [Storing and Travelling With a GLP-1: Cold Chain, Airports and What Breaks](https://glp1tirzepatideranked.com/storage-and-travel/) — glp-1 storage travel
  These are refrigerated biologics with defined storage conditions and a limited room-temperature allowance. The practical risks are a broken cold chain in transit, and airport security — which is manageable, because medication and cooling accessories are permitted in carry-on, and carry-on is where t
- [Switching GLP-1 Providers: The Practical and Clinical Steps](https://glp1tirzepatideranked.com/switching-glp1-providers/) — switching glp-1 providers
  Establish four things before cancelling anything: what your current preparation actually is, what the new provider would prescribe, what happens to any prepaid balance, and whether there is a supply gap between them. Compounded preparations are not bioequivalence-tested, so doses do not map automati
- [Tirzepatide Dosage Chart: The Label Schedule, and What It Costs at Each Step](https://glp1tirzepatideranked.com/tirzepatide-dosage-chart/) — tirzepatide dosage chart
  The label directs 2.5 mg once weekly for four weeks, then 5 mg, then increases in 2.5 mg steps no sooner than every four weeks. It names 5, 10 and 15 mg as recommended maintenance dosages and states plainly that 2.5 mg is treatment initiation and is not approved as a maintenance dosage. Reaching 15 
- [Tirzepatide: Cost, Dosing, Evidence and Every Route to Get It](https://glp1tirzepatideranked.com/tirzepatide/) — tirzepatide
  Tirzepatide is a dual GIP and GLP-1 receptor agonist sold as Zepbound for weight management and Mounjaro for type 2 diabetes. SURMOUNT-1 reported up to 22.5% mean body-weight reduction at 15 mg over 72 weeks. Brand self-pay is $299 to $449 through LillyDirect; the only compounded pricing we captured
- [Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026)](https://glp1tirzepatideranked.com/tirzepatide/cheapest/) — cheapest tirzepatide online
  There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required. Compounded programmes run $147 to $399 a month, brand Zepbound is $299 to $449 direct, and coverage beats both — roughly $25 with a commercial plan, $50 on the Medi
- [Provider Match: Ten Questions, Then What the Evidence Supports](https://glp1tirzepatideranked.com/tools/provider-match/) — glp-1 provider match
  Answer ten questions and this tool ranks providers against what actually constrains you rather than against an advertised entry price. It runs entirely in your browser, sends nothing anywhere, and shows its scoring. Where we hold no captured price for a provider, it says so instead of guessing.
- [Zepbound Savings: Every Legitimate Route, and What Each Actually Costs](https://glp1tirzepatideranked.com/zepbound-savings-card/) — zepbound coupon
  Four routes exist and they do not stack. With commercial coverage the savings card commonly brings the copay near $25 a month. Without coverage, LillyDirect self-pay is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg up — figures we captured from Lilly's own pages on 27 July 2026.

## News desk
- [ADA 2026: Adding a Myostatin Inhibitor Cut the Lean-Mass Share of Weight Loss From 21% to 7%](https://glp1tirzepatideranked.com/news/ada-2026-bimagrumab-lean-mass/) — event 2026-06-22, published 2026-07-24
- [ADA 2026: Semaglutide Improved Knee Osteoarthritis Pain — and Tirzepatide's Extra Weight Loss Did Not Add More](https://glp1tirzepatideranked.com/news/ada-2026-osteoarthritis-outcomes/) — event 2026-06-22, published 2026-07-24
- [CMS Delays the BALANCE Model Indefinitely and Extends the GLP-1 Bridge Instead](https://glp1tirzepatideranked.com/news/balance-model-part-d-delayed/) — event 2026-05-01, published 2026-07-24
- [CMS proposes barring Medicare payment for outsourced remote monitoring](https://glp1tirzepatideranked.com/news/cms-2027-remote-monitoring-outsourcing/) — event 2026-07-16, published 2026-07-28
- [A 2026 Study Finds Tirzepatide and B12 Can Chemically Bond — Forming a Molecule Not in the Approved Drug](https://glp1tirzepatideranked.com/news/compounded-b12-chemical-bonding-study/) — event 2026-07-01, published 2026-07-24
- [EVOKE and EVOKE+: Oral Semaglutide Made No Difference to Alzheimer's Progression](https://glp1tirzepatideranked.com/news/evoke-alzheimers-null-result/) — event 2026-06-08, published 2026-07-24
- [FDA Sends 25 More Warning Letters Over Compounded GLP-1 Marketing Claims](https://glp1tirzepatideranked.com/news/fda-25-warning-letters-june-2026/) — event 2026-06-16, published 2026-07-24
- [FDA Proposes Permanent Exclusion of Semaglutide, Tirzepatide and Liraglutide From the 503B Bulks List](https://glp1tirzepatideranked.com/news/fda-503b-bulks-exclusion-proposal/) — event 2026-04-30, published 2026-07-24
- [Comment Period on the GLP-1 Bulks Proposal Extended to 30 July](https://glp1tirzepatideranked.com/news/fda-comment-period-extension-503b/) — event 2026-06-26, published 2026-07-24
- [FDA Signals It Will Restrict GLP-1 Active Ingredients Used in Non-Approved Compounded Products](https://glp1tirzepatideranked.com/news/fda-february-2026-api-restriction/) — event 2026-02-06, published 2026-07-24
- [FDA Panel Recommends Six of Seven Peptides for Compounding, Overriding Its Own Scientists](https://glp1tirzepatideranked.com/news/fda-panel-votes-peptides-503a-july-2026/) — event 2026-07-23, published 2026-07-25
- [FDA Advisory Committee Reviews BPC-157, TB-500 and Five Other Peptides This Week](https://glp1tirzepatideranked.com/news/fda-peptide-advisory-committee-july-2026/) — event 2026-07-23, published 2026-07-24
- [Foundayo is $149 self-pay, and the Complete Response Letter claim is false](https://glp1tirzepatideranked.com/news/foundayo-cost-and-the-crl-claim/) — event 2026-07-29, published 2026-07-29
- [FDA Approves Foundayo (Orforglipron), the First Small-Molecule Oral GLP-1 for Weight Loss](https://glp1tirzepatideranked.com/news/foundayo-orforglipron-fda-approval/) — event 2026-04-01, published 2026-07-24
- [GLP-1 Use Reaches 11% of US Adults as the Obesity Rate Falls to 36.4%](https://glp1tirzepatideranked.com/news/gallup-glp1-use-obesity-decline/) — event 2026-07-10, published 2026-07-24
- [Sandoz and Amneal File for Generic Tirzepatide — But Lilly's Patents Run to 2036](https://glp1tirzepatideranked.com/news/generic-tirzepatide-anda-filings/) — event 2026-07-04, published 2026-07-24
- [A Major Telehealth Platform Withdrew a Compounded Copy of the Wegovy Pill Under Legal Threat](https://glp1tirzepatideranked.com/news/hims-compounded-wegovy-pill-withdrawal/) — event 2026-02-20, published 2026-07-24
- [Physician sentenced to 40 months for signing telemedicine orders for patients he never examined](https://glp1tirzepatideranked.com/news/idaho-physician-sentenced-telemedicine-orders/) — event 2026-07-08, published 2026-07-28
- [Medicare GLP-1 Bridge Opens: $50 a Month for Eligible Part D Enrollees](https://glp1tirzepatideranked.com/news/medicare-glp1-bridge-launches/) — event 2026-07-01, published 2026-07-24
- [Telehealth company drops compounded semaglutide ad claims after Novo challenge](https://glp1tirzepatideranked.com/news/nad-willow-compounded-semaglutide-claims/) — event 2026-07-24, published 2026-07-28
- [First provider in our dataset names its fulfilment pharmacies](https://glp1tirzepatideranked.com/news/nexlife-names-fulfilment-pharmacies/) — event 2026-07-27, published 2026-07-28
- [NovoCare Cuts Wegovy Self-Pay Pricing to $349 From $499](https://glp1tirzepatideranked.com/news/novocare-wegovy-price-cut/) — event 2025-11-01, published 2026-07-24
- [Ozempic is about $998 a month cash. Almost every saving comes from not buying Ozempic](https://glp1tirzepatideranked.com/news/ozempic-cash-price-and-the-cheaper-routes/) — event 2026-07-29, published 2026-07-29
- [REIMAGINE 2: CagriSema Beats Semaglutide on HbA1c by 1.91 Points With 14.2% Weight Loss](https://glp1tirzepatideranked.com/news/reimagine-2-cagrisema-diabetes/) — event 2026-06-30, published 2026-07-24
- [Semaglutide Came Off the Shortage List in February 2025 — With a May Deadline for Outsourcing Facilities](https://glp1tirzepatideranked.com/news/semaglutide-shortage-resolved-enforcement/) — event 2025-02-21, published 2026-07-24
- [SOUL: Oral Semaglutide Cuts Major Cardiovascular Events by 14% in High-Risk Type 2 Diabetes](https://glp1tirzepatideranked.com/news/soul-trial-oral-semaglutide-cardiovascular/) — event 2026-06-10, published 2026-07-24
- [STEP UP: Semaglutide 7.2 mg Reports 20.7% Weight Loss, Narrowing the Gap With Tirzepatide](https://glp1tirzepatideranked.com/news/step-up-semaglutide-7-2mg/) — event 2026-06-13, published 2026-07-24
- [ACCESS II: A Second Oral Small-Molecule GLP-1 Posts 16.3% Placebo-Adjusted Weight Loss](https://glp1tirzepatideranked.com/news/structure-therapeutics-oral-access-ii/) — event 2026-06-29, published 2026-07-24
- [SUMMIT: Tirzepatide Cuts Worsening Heart-Failure Events by 38% in Obesity-Related HFpEF](https://glp1tirzepatideranked.com/news/summit-hfpef-results/) — event 2024-11-16, published 2026-07-24
- [Three Years of Tirzepatide Markedly Reduced Progression to Type 2 Diabetes in Prediabetes](https://glp1tirzepatideranked.com/news/surmount-1-three-year-diabetes-prevention/) — event 2024-11-13, published 2026-07-24
- [SURMOUNT-5 Published: Tirzepatide 20.2% Against Semaglutide 13.7% in the First Head-to-Head](https://glp1tirzepatideranked.com/news/surmount-5-published-nejm/) — event 2025-05-11, published 2026-07-24
- [SYNCHRONIZE-1: 16.6% Weight Loss With 34% Less Visceral Fat and 63% Less Liver Fat](https://glp1tirzepatideranked.com/news/synchronize-1-visceral-liver-fat/) — event 2026-06-11, published 2026-07-24
- [The Tirzepatide Shortage Delisting Was Not One Date — It Was a Year of Litigation](https://glp1tirzepatideranked.com/news/tirzepatide-shortage-timeline-litigation/) — event 2024-10-02, published 2026-07-24
- [Telehealth group agrees consent judgment of up to $600,000 over controlled substance allegations](https://glp1tirzepatideranked.com/news/total-mens-primary-care-csa-settlement/) — event 2026-07-24, published 2026-07-28
- [TrumpRx Launches Direct GLP-1 Pricing, Undercutting List Prices by Up to Nine Times](https://glp1tirzepatideranked.com/news/trumprx-launch-direct-pricing/) — event 2026-02-05, published 2026-07-24
- [FDA Approves the Wegovy Pill: Oral Semaglutide 25 mg for Weight Management](https://glp1tirzepatideranked.com/news/wegovy-pill-oral-semaglutide-approval/) — event 2025-12-22, published 2026-07-24
- [The Wegovy Pill Passed Three Million Prescriptions in Just Over Five Months](https://glp1tirzepatideranked.com/news/wegovy-pill-three-million-prescriptions/) — event 2026-06-15, published 2026-07-24
- [Zepbound Now Carries an Obstructive Sleep Apnoea Indication Alongside Weight Management](https://glp1tirzepatideranked.com/news/zepbound-osa-indication/) — event 2026-01-15, published 2026-07-24

## Provider comparisons
406 head-to-head pages, each generated from our captured price records rather than from a template. Every one states both providers' evidence status and the fields neither has disclosed.
- [bmiMD vs Calibrate](https://glp1tirzepatideranked.com/compare/bmimd-vs-calibrate/)
- [bmiMD vs Eden](https://glp1tirzepatideranked.com/compare/bmimd-vs-eden/)
- [bmiMD vs Embody](https://glp1tirzepatideranked.com/compare/bmimd-vs-embody/)
- [bmiMD vs Enhance.MD](https://glp1tirzepatideranked.com/compare/bmimd-vs-enhance-md/)
- [bmiMD vs Fifty 410](https://glp1tirzepatideranked.com/compare/bmimd-vs-fifty-410/)
- [bmiMD vs Form Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-form-health/)
- [bmiMD vs Found](https://glp1tirzepatideranked.com/compare/bmimd-vs-found/)
- [bmiMD vs Henry Meds](https://glp1tirzepatideranked.com/compare/bmimd-vs-henry-meds/)
- [bmiMD vs Hims](https://glp1tirzepatideranked.com/compare/bmimd-vs-hims-hers/)
- [bmiMD vs IVIM Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-ivim-health/)
- [bmiMD vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-lavender-sky-health/)
- [bmiMD vs LillyDirect](https://glp1tirzepatideranked.com/compare/bmimd-vs-lillydirect/)
- [bmiMD vs MEDVi](https://glp1tirzepatideranked.com/compare/bmimd-vs-medvi/)
- [bmiMD vs Mochi Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-mochi-health/)
- [bmiMD vs NexLife](https://glp1tirzepatideranked.com/compare/bmimd-vs-nexlife/)
- [bmiMD vs Noom Med](https://glp1tirzepatideranked.com/compare/bmimd-vs-noom-med/)
- [bmiMD vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/bmimd-vs-novocare/)
- [bmiMD vs Oak Longevity](https://glp1tirzepatideranked.com/compare/bmimd-vs-oak-longevity/)
- [bmiMD vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/bmimd-vs-orderlymeds/)
- [bmiMD vs PlushCare](https://glp1tirzepatideranked.com/compare/bmimd-vs-plushcare/)
- [bmiMD vs Ro](https://glp1tirzepatideranked.com/compare/bmimd-vs-ro-body/)
- [bmiMD vs Shed](https://glp1tirzepatideranked.com/compare/bmimd-vs-shed/)
- [bmiMD vs SkinnyRx](https://glp1tirzepatideranked.com/compare/bmimd-vs-skinnyrx/)
- [bmiMD vs Trimi](https://glp1tirzepatideranked.com/compare/bmimd-vs-trimi/)
- [bmiMD vs TrimRx](https://glp1tirzepatideranked.com/compare/bmimd-vs-trimrx/)
- [bmiMD vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/bmimd-vs-weightwatchers-clinic/)
- [bmiMD vs Yucca Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-yucca-health/)
- [bmiMD vs Zappy Health](https://glp1tirzepatideranked.com/compare/bmimd-vs-zappy-health/)
- [Calibrate vs Eden](https://glp1tirzepatideranked.com/compare/calibrate-vs-eden/)
- [Calibrate vs Embody](https://glp1tirzepatideranked.com/compare/calibrate-vs-embody/)
- [Calibrate vs Enhance.MD](https://glp1tirzepatideranked.com/compare/calibrate-vs-enhance-md/)
- [Calibrate vs Fifty 410](https://glp1tirzepatideranked.com/compare/calibrate-vs-fifty-410/)
- [Calibrate vs Form Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-form-health/)
- [Calibrate vs Found](https://glp1tirzepatideranked.com/compare/calibrate-vs-found/)
- [Calibrate vs Henry Meds](https://glp1tirzepatideranked.com/compare/calibrate-vs-henry-meds/)
- [Calibrate vs Hims](https://glp1tirzepatideranked.com/compare/calibrate-vs-hims-hers/)
- [Calibrate vs IVIM Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-ivim-health/)
- [Calibrate vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-lavender-sky-health/)
- [Calibrate vs LillyDirect](https://glp1tirzepatideranked.com/compare/calibrate-vs-lillydirect/)
- [Calibrate vs MEDVi](https://glp1tirzepatideranked.com/compare/calibrate-vs-medvi/)
- [Calibrate vs Mochi Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-mochi-health/)
- [Calibrate vs NexLife](https://glp1tirzepatideranked.com/compare/calibrate-vs-nexlife/)
- [Calibrate vs Noom Med](https://glp1tirzepatideranked.com/compare/calibrate-vs-noom-med/)
- [Calibrate vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/calibrate-vs-novocare/)
- [Calibrate vs Oak Longevity](https://glp1tirzepatideranked.com/compare/calibrate-vs-oak-longevity/)
- [Calibrate vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/calibrate-vs-orderlymeds/)
- [Calibrate vs PlushCare](https://glp1tirzepatideranked.com/compare/calibrate-vs-plushcare/)
- [Calibrate vs Ro](https://glp1tirzepatideranked.com/compare/calibrate-vs-ro-body/)
- [Calibrate vs Shed](https://glp1tirzepatideranked.com/compare/calibrate-vs-shed/)
- [Calibrate vs SkinnyRx](https://glp1tirzepatideranked.com/compare/calibrate-vs-skinnyrx/)
- [Calibrate vs Trimi](https://glp1tirzepatideranked.com/compare/calibrate-vs-trimi/)
- [Calibrate vs TrimRx](https://glp1tirzepatideranked.com/compare/calibrate-vs-trimrx/)
- [Calibrate vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/calibrate-vs-weightwatchers-clinic/)
- [Calibrate vs Yucca Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-yucca-health/)
- [Calibrate vs Zappy Health](https://glp1tirzepatideranked.com/compare/calibrate-vs-zappy-health/)
- [Eden vs Embody](https://glp1tirzepatideranked.com/compare/eden-vs-embody/)
- [Eden vs Enhance.MD](https://glp1tirzepatideranked.com/compare/eden-vs-enhance-md/)
- [Eden vs Fifty 410](https://glp1tirzepatideranked.com/compare/eden-vs-fifty-410/)
- [Eden vs Form Health](https://glp1tirzepatideranked.com/compare/eden-vs-form-health/)
- [Eden vs Found](https://glp1tirzepatideranked.com/compare/eden-vs-found/)
- [Eden vs Henry Meds](https://glp1tirzepatideranked.com/compare/eden-vs-henry-meds/)
- [Eden vs Hims](https://glp1tirzepatideranked.com/compare/eden-vs-hims-hers/)
- [Eden vs IVIM Health](https://glp1tirzepatideranked.com/compare/eden-vs-ivim-health/)
- [Eden vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/eden-vs-lavender-sky-health/)
- [Eden vs LillyDirect](https://glp1tirzepatideranked.com/compare/eden-vs-lillydirect/)
- [Eden vs MEDVi](https://glp1tirzepatideranked.com/compare/eden-vs-medvi/)
- [Eden vs Mochi Health](https://glp1tirzepatideranked.com/compare/eden-vs-mochi-health/)
- [Eden vs NexLife](https://glp1tirzepatideranked.com/compare/eden-vs-nexlife/)
- [Eden vs Noom Med](https://glp1tirzepatideranked.com/compare/eden-vs-noom-med/)
- [Eden vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/eden-vs-novocare/)
- [Eden vs Oak Longevity](https://glp1tirzepatideranked.com/compare/eden-vs-oak-longevity/)
- [Eden vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/eden-vs-orderlymeds/)
- [Eden vs PlushCare](https://glp1tirzepatideranked.com/compare/eden-vs-plushcare/)
- [Eden vs Ro](https://glp1tirzepatideranked.com/compare/eden-vs-ro-body/)
- [Eden vs Shed](https://glp1tirzepatideranked.com/compare/eden-vs-shed/)
- [Eden vs SkinnyRx](https://glp1tirzepatideranked.com/compare/eden-vs-skinnyrx/)
- [Eden vs Trimi](https://glp1tirzepatideranked.com/compare/eden-vs-trimi/)
- [Eden vs TrimRx](https://glp1tirzepatideranked.com/compare/eden-vs-trimrx/)
- [Eden vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/eden-vs-weightwatchers-clinic/)
- [Eden vs Yucca Health](https://glp1tirzepatideranked.com/compare/eden-vs-yucca-health/)
- [Eden vs Zappy Health](https://glp1tirzepatideranked.com/compare/eden-vs-zappy-health/)
- [Embody vs Enhance.MD](https://glp1tirzepatideranked.com/compare/embody-vs-enhance-md/)
- [Embody vs Fifty 410](https://glp1tirzepatideranked.com/compare/embody-vs-fifty-410/)
- [Embody vs Form Health](https://glp1tirzepatideranked.com/compare/embody-vs-form-health/)
- [Embody vs Found](https://glp1tirzepatideranked.com/compare/embody-vs-found/)
- [Embody vs Henry Meds](https://glp1tirzepatideranked.com/compare/embody-vs-henry-meds/)
- [Embody vs Hims](https://glp1tirzepatideranked.com/compare/embody-vs-hims-hers/)
- [Embody vs IVIM Health](https://glp1tirzepatideranked.com/compare/embody-vs-ivim-health/)
- [Embody vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/embody-vs-lavender-sky-health/)
- [Embody vs LillyDirect](https://glp1tirzepatideranked.com/compare/embody-vs-lillydirect/)
- [Embody vs MEDVi](https://glp1tirzepatideranked.com/compare/embody-vs-medvi/)
- [Embody vs Mochi Health](https://glp1tirzepatideranked.com/compare/embody-vs-mochi-health/)
- [Embody vs NexLife](https://glp1tirzepatideranked.com/compare/embody-vs-nexlife/)
- [Embody vs Noom Med](https://glp1tirzepatideranked.com/compare/embody-vs-noom-med/)
- [Embody vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/embody-vs-novocare/)
- [Embody vs Oak Longevity](https://glp1tirzepatideranked.com/compare/embody-vs-oak-longevity/)
- [Embody vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/embody-vs-orderlymeds/)
- [Embody vs PlushCare](https://glp1tirzepatideranked.com/compare/embody-vs-plushcare/)
- [Embody vs Ro](https://glp1tirzepatideranked.com/compare/embody-vs-ro-body/)
- [Embody vs Shed](https://glp1tirzepatideranked.com/compare/embody-vs-shed/)
- [Embody vs SkinnyRx](https://glp1tirzepatideranked.com/compare/embody-vs-skinnyrx/)
- [Embody vs Trimi](https://glp1tirzepatideranked.com/compare/embody-vs-trimi/)
- [Embody vs TrimRx](https://glp1tirzepatideranked.com/compare/embody-vs-trimrx/)
- [Embody vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/embody-vs-weightwatchers-clinic/)
- [Embody vs Yucca Health](https://glp1tirzepatideranked.com/compare/embody-vs-yucca-health/)
- [Embody vs Zappy Health](https://glp1tirzepatideranked.com/compare/embody-vs-zappy-health/)
- [Enhance.MD vs Fifty 410](https://glp1tirzepatideranked.com/compare/enhance-md-vs-fifty-410/)
- [Enhance.MD vs Form Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-form-health/)
- [Enhance.MD vs Found](https://glp1tirzepatideranked.com/compare/enhance-md-vs-found/)
- [Enhance.MD vs Henry Meds](https://glp1tirzepatideranked.com/compare/enhance-md-vs-henry-meds/)
- [Enhance.MD vs Hims](https://glp1tirzepatideranked.com/compare/enhance-md-vs-hims-hers/)
- [Enhance.MD vs IVIM Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-ivim-health/)
- [Enhance.MD vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-lavender-sky-health/)
- [Enhance.MD vs LillyDirect](https://glp1tirzepatideranked.com/compare/enhance-md-vs-lillydirect/)
- [Enhance.MD vs MEDVi](https://glp1tirzepatideranked.com/compare/enhance-md-vs-medvi/)
- [Enhance.MD vs Mochi Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-mochi-health/)
- [Enhance.MD vs NexLife](https://glp1tirzepatideranked.com/compare/enhance-md-vs-nexlife/)
- [Enhance.MD vs Noom Med](https://glp1tirzepatideranked.com/compare/enhance-md-vs-noom-med/)
- [Enhance.MD vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/enhance-md-vs-novocare/)
- [Enhance.MD vs Oak Longevity](https://glp1tirzepatideranked.com/compare/enhance-md-vs-oak-longevity/)
- [Enhance.MD vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/enhance-md-vs-orderlymeds/)
- [Enhance.MD vs PlushCare](https://glp1tirzepatideranked.com/compare/enhance-md-vs-plushcare/)
- [Enhance.MD vs Ro](https://glp1tirzepatideranked.com/compare/enhance-md-vs-ro-body/)
- [Enhance.MD vs Shed](https://glp1tirzepatideranked.com/compare/enhance-md-vs-shed/)
- [Enhance.MD vs SkinnyRx](https://glp1tirzepatideranked.com/compare/enhance-md-vs-skinnyrx/)
- [Enhance.MD vs Trimi](https://glp1tirzepatideranked.com/compare/enhance-md-vs-trimi/)
- [Enhance.MD vs TrimRx](https://glp1tirzepatideranked.com/compare/enhance-md-vs-trimrx/)
- [Enhance.MD vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/enhance-md-vs-weightwatchers-clinic/)
- [Enhance.MD vs Yucca Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-yucca-health/)
- [Enhance.MD vs Zappy Health](https://glp1tirzepatideranked.com/compare/enhance-md-vs-zappy-health/)
- [Fifty 410 vs Form Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-form-health/)
- [Fifty 410 vs Found](https://glp1tirzepatideranked.com/compare/fifty-410-vs-found/)
- [Fifty 410 vs Henry Meds](https://glp1tirzepatideranked.com/compare/fifty-410-vs-henry-meds/)
- [Fifty 410 vs Hims](https://glp1tirzepatideranked.com/compare/fifty-410-vs-hims-hers/)
- [Fifty 410 vs IVIM Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-ivim-health/)
- [Fifty 410 vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-lavender-sky-health/)
- [Fifty 410 vs LillyDirect](https://glp1tirzepatideranked.com/compare/fifty-410-vs-lillydirect/)
- [Fifty 410 vs MEDVi](https://glp1tirzepatideranked.com/compare/fifty-410-vs-medvi/)
- [Fifty 410 vs Mochi Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-mochi-health/)
- [Fifty 410 vs NexLife](https://glp1tirzepatideranked.com/compare/fifty-410-vs-nexlife/)
- [Fifty 410 vs Noom Med](https://glp1tirzepatideranked.com/compare/fifty-410-vs-noom-med/)
- [Fifty 410 vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/fifty-410-vs-novocare/)
- [Fifty 410 vs Oak Longevity](https://glp1tirzepatideranked.com/compare/fifty-410-vs-oak-longevity/)
- [Fifty 410 vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/fifty-410-vs-orderlymeds/)
- [Fifty 410 vs PlushCare](https://glp1tirzepatideranked.com/compare/fifty-410-vs-plushcare/)
- [Fifty 410 vs Ro](https://glp1tirzepatideranked.com/compare/fifty-410-vs-ro-body/)
- [Fifty 410 vs Shed](https://glp1tirzepatideranked.com/compare/fifty-410-vs-shed/)
- [Fifty 410 vs SkinnyRx](https://glp1tirzepatideranked.com/compare/fifty-410-vs-skinnyrx/)
- [Fifty 410 vs Trimi](https://glp1tirzepatideranked.com/compare/fifty-410-vs-trimi/)
- [Fifty 410 vs TrimRx](https://glp1tirzepatideranked.com/compare/fifty-410-vs-trimrx/)
- [Fifty 410 vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/fifty-410-vs-weightwatchers-clinic/)
- [Fifty 410 vs Yucca Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-yucca-health/)
- [Fifty 410 vs Zappy Health](https://glp1tirzepatideranked.com/compare/fifty-410-vs-zappy-health/)
- [Form Health vs Found](https://glp1tirzepatideranked.com/compare/form-health-vs-found/)
- [Form Health vs Henry Meds](https://glp1tirzepatideranked.com/compare/form-health-vs-henry-meds/)
- [Form Health vs Hims](https://glp1tirzepatideranked.com/compare/form-health-vs-hims-hers/)
- [Form Health vs IVIM Health](https://glp1tirzepatideranked.com/compare/form-health-vs-ivim-health/)
- [Form Health vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/form-health-vs-lavender-sky-health/)
- [Form Health vs LillyDirect](https://glp1tirzepatideranked.com/compare/form-health-vs-lillydirect/)
- [Form Health vs MEDVi](https://glp1tirzepatideranked.com/compare/form-health-vs-medvi/)
- [Form Health vs Mochi Health](https://glp1tirzepatideranked.com/compare/form-health-vs-mochi-health/)
- [Form Health vs NexLife](https://glp1tirzepatideranked.com/compare/form-health-vs-nexlife/)
- [Form Health vs Noom Med](https://glp1tirzepatideranked.com/compare/form-health-vs-noom-med/)
- [Form Health vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/form-health-vs-novocare/)
- [Form Health vs Oak Longevity](https://glp1tirzepatideranked.com/compare/form-health-vs-oak-longevity/)
- [Form Health vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/form-health-vs-orderlymeds/)
- [Form Health vs PlushCare](https://glp1tirzepatideranked.com/compare/form-health-vs-plushcare/)
- [Form Health vs Ro](https://glp1tirzepatideranked.com/compare/form-health-vs-ro-body/)
- [Form Health vs Shed](https://glp1tirzepatideranked.com/compare/form-health-vs-shed/)
- [Form Health vs SkinnyRx](https://glp1tirzepatideranked.com/compare/form-health-vs-skinnyrx/)
- [Form Health vs Trimi](https://glp1tirzepatideranked.com/compare/form-health-vs-trimi/)
- [Form Health vs TrimRx](https://glp1tirzepatideranked.com/compare/form-health-vs-trimrx/)
- [Form Health vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/form-health-vs-weightwatchers-clinic/)
- [Form Health vs Yucca Health](https://glp1tirzepatideranked.com/compare/form-health-vs-yucca-health/)
- [Form Health vs Zappy Health](https://glp1tirzepatideranked.com/compare/form-health-vs-zappy-health/)
- [Found vs Henry Meds](https://glp1tirzepatideranked.com/compare/found-vs-henry-meds/)
- [Found vs Hims](https://glp1tirzepatideranked.com/compare/found-vs-hims-hers/)
- [Found vs IVIM Health](https://glp1tirzepatideranked.com/compare/found-vs-ivim-health/)
- [Found vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/found-vs-lavender-sky-health/)
- [Found vs LillyDirect](https://glp1tirzepatideranked.com/compare/found-vs-lillydirect/)
- [Found vs MEDVi](https://glp1tirzepatideranked.com/compare/found-vs-medvi/)
- [Found vs Mochi Health](https://glp1tirzepatideranked.com/compare/found-vs-mochi-health/)
- [Found vs NexLife](https://glp1tirzepatideranked.com/compare/found-vs-nexlife/)
- [Found vs Noom Med](https://glp1tirzepatideranked.com/compare/found-vs-noom-med/)
- [Found vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/found-vs-novocare/)
- [Found vs Oak Longevity](https://glp1tirzepatideranked.com/compare/found-vs-oak-longevity/)
- [Found vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/found-vs-orderlymeds/)
- [Found vs PlushCare](https://glp1tirzepatideranked.com/compare/found-vs-plushcare/)
- [Found vs Ro](https://glp1tirzepatideranked.com/compare/found-vs-ro-body/)
- [Found vs Shed](https://glp1tirzepatideranked.com/compare/found-vs-shed/)
- [Found vs SkinnyRx](https://glp1tirzepatideranked.com/compare/found-vs-skinnyrx/)
- [Found vs Trimi](https://glp1tirzepatideranked.com/compare/found-vs-trimi/)
- [Found vs TrimRx](https://glp1tirzepatideranked.com/compare/found-vs-trimrx/)
- [Found vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/found-vs-weightwatchers-clinic/)
- [Found vs Yucca Health](https://glp1tirzepatideranked.com/compare/found-vs-yucca-health/)
- [Found vs Zappy Health](https://glp1tirzepatideranked.com/compare/found-vs-zappy-health/)
- [Henry Meds vs Hims](https://glp1tirzepatideranked.com/compare/henry-meds-vs-hims-hers/)
- [Henry Meds vs IVIM Health](https://glp1tirzepatideranked.com/compare/henry-meds-vs-ivim-health/)
- [Henry Meds vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/henry-meds-vs-lavender-sky-health/)
- [Henry Meds vs LillyDirect](https://glp1tirzepatideranked.com/compare/henry-meds-vs-lillydirect/)
- [Henry Meds vs MEDVi](https://glp1tirzepatideranked.com/compare/henry-meds-vs-medvi/)
- [Henry Meds vs Mochi Health](https://glp1tirzepatideranked.com/compare/henry-meds-vs-mochi-health/)
- [Henry Meds vs NexLife](https://glp1tirzepatideranked.com/compare/henry-meds-vs-nexlife/)
- [Henry Meds vs Noom Med](https://glp1tirzepatideranked.com/compare/henry-meds-vs-noom-med/)
- [Henry Meds vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/henry-meds-vs-novocare/)
- [Henry Meds vs Oak Longevity](https://glp1tirzepatideranked.com/compare/henry-meds-vs-oak-longevity/)
- [Henry Meds vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/henry-meds-vs-orderlymeds/)
- [Henry Meds vs PlushCare](https://glp1tirzepatideranked.com/compare/henry-meds-vs-plushcare/)
- [Henry Meds vs Ro](https://glp1tirzepatideranked.com/compare/henry-meds-vs-ro-body/)
- [Henry Meds vs Shed](https://glp1tirzepatideranked.com/compare/henry-meds-vs-shed/)
- [Henry Meds vs SkinnyRx](https://glp1tirzepatideranked.com/compare/henry-meds-vs-skinnyrx/)
- [Henry Meds vs Trimi](https://glp1tirzepatideranked.com/compare/henry-meds-vs-trimi/)
- [Henry Meds vs TrimRx](https://glp1tirzepatideranked.com/compare/henry-meds-vs-trimrx/)
- [Henry Meds vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/henry-meds-vs-weightwatchers-clinic/)
- [Henry Meds vs Yucca Health](https://glp1tirzepatideranked.com/compare/henry-meds-vs-yucca-health/)
- [Henry Meds vs Zappy Health](https://glp1tirzepatideranked.com/compare/henry-meds-vs-zappy-health/)
- [Hims vs IVIM Health](https://glp1tirzepatideranked.com/compare/hims-hers-vs-ivim-health/)
- [Hims vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/hims-hers-vs-lavender-sky-health/)
- [Hims vs LillyDirect](https://glp1tirzepatideranked.com/compare/hims-hers-vs-lillydirect/)
- [Hims vs MEDVi](https://glp1tirzepatideranked.com/compare/hims-hers-vs-medvi/)
- [Hims vs Mochi Health](https://glp1tirzepatideranked.com/compare/hims-hers-vs-mochi-health/)
- [Hims vs NexLife](https://glp1tirzepatideranked.com/compare/hims-hers-vs-nexlife/)
- [Hims vs Noom Med](https://glp1tirzepatideranked.com/compare/hims-hers-vs-noom-med/)
- [Hims vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/hims-hers-vs-novocare/)
- [Hims vs Oak Longevity](https://glp1tirzepatideranked.com/compare/hims-hers-vs-oak-longevity/)
- [Hims vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/hims-hers-vs-orderlymeds/)
- [Hims vs PlushCare](https://glp1tirzepatideranked.com/compare/hims-hers-vs-plushcare/)
- [Hims vs Ro](https://glp1tirzepatideranked.com/compare/hims-hers-vs-ro-body/)
- [Hims vs Shed](https://glp1tirzepatideranked.com/compare/hims-hers-vs-shed/)
- [Hims vs SkinnyRx](https://glp1tirzepatideranked.com/compare/hims-hers-vs-skinnyrx/)
- [Hims vs Trimi](https://glp1tirzepatideranked.com/compare/hims-hers-vs-trimi/)
- [Hims vs TrimRx](https://glp1tirzepatideranked.com/compare/hims-hers-vs-trimrx/)
- [Hims vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/hims-hers-vs-weightwatchers-clinic/)
- [Hims vs Yucca Health](https://glp1tirzepatideranked.com/compare/hims-hers-vs-yucca-health/)
- [Hims vs Zappy Health](https://glp1tirzepatideranked.com/compare/hims-hers-vs-zappy-health/)
- [IVIM Health vs Lavender Sky Health](https://glp1tirzepatideranked.com/compare/ivim-health-vs-lavender-sky-health/)
- [IVIM Health vs LillyDirect](https://glp1tirzepatideranked.com/compare/ivim-health-vs-lillydirect/)
- [IVIM Health vs MEDVi](https://glp1tirzepatideranked.com/compare/ivim-health-vs-medvi/)
- [IVIM Health vs Mochi Health](https://glp1tirzepatideranked.com/compare/ivim-health-vs-mochi-health/)
- [IVIM Health vs NexLife](https://glp1tirzepatideranked.com/compare/ivim-health-vs-nexlife/)
- [IVIM Health vs Noom Med](https://glp1tirzepatideranked.com/compare/ivim-health-vs-noom-med/)
- [IVIM Health vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/ivim-health-vs-novocare/)
- [IVIM Health vs Oak Longevity](https://glp1tirzepatideranked.com/compare/ivim-health-vs-oak-longevity/)
- [IVIM Health vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/ivim-health-vs-orderlymeds/)
- [IVIM Health vs PlushCare](https://glp1tirzepatideranked.com/compare/ivim-health-vs-plushcare/)
- [IVIM Health vs Ro](https://glp1tirzepatideranked.com/compare/ivim-health-vs-ro-body/)
- [IVIM Health vs Shed](https://glp1tirzepatideranked.com/compare/ivim-health-vs-shed/)
- [IVIM Health vs SkinnyRx](https://glp1tirzepatideranked.com/compare/ivim-health-vs-skinnyrx/)
- [IVIM Health vs Trimi](https://glp1tirzepatideranked.com/compare/ivim-health-vs-trimi/)
- [IVIM Health vs TrimRx](https://glp1tirzepatideranked.com/compare/ivim-health-vs-trimrx/)
- [IVIM Health vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/ivim-health-vs-weightwatchers-clinic/)
- [IVIM Health vs Yucca Health](https://glp1tirzepatideranked.com/compare/ivim-health-vs-yucca-health/)
- [IVIM Health vs Zappy Health](https://glp1tirzepatideranked.com/compare/ivim-health-vs-zappy-health/)
- [Lavender Sky Health vs LillyDirect](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-lillydirect/)
- [Lavender Sky Health vs MEDVi](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-medvi/)
- [Lavender Sky Health vs Mochi Health](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-mochi-health/)
- [Lavender Sky Health vs NexLife](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-nexlife/)
- [Lavender Sky Health vs Noom Med](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-noom-med/)
- [Lavender Sky Health vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-novocare/)
- [Lavender Sky Health vs Oak Longevity](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-oak-longevity/)
- [Lavender Sky Health vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-orderlymeds/)
- [Lavender Sky Health vs PlushCare](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-plushcare/)
- [Lavender Sky Health vs Ro](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-ro-body/)
- [Lavender Sky Health vs Shed](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-shed/)
- [Lavender Sky Health vs SkinnyRx](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-skinnyrx/)
- [Lavender Sky Health vs Trimi](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-trimi/)
- [Lavender Sky Health vs TrimRx](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-trimrx/)
- [Lavender Sky Health vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-weightwatchers-clinic/)
- [Lavender Sky Health vs Yucca Health](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-yucca-health/)
- [Lavender Sky Health vs Zappy Health](https://glp1tirzepatideranked.com/compare/lavender-sky-health-vs-zappy-health/)
- [LillyDirect vs MEDVi](https://glp1tirzepatideranked.com/compare/lillydirect-vs-medvi/)
- [LillyDirect vs Mochi Health](https://glp1tirzepatideranked.com/compare/lillydirect-vs-mochi-health/)
- [LillyDirect vs NexLife](https://glp1tirzepatideranked.com/compare/lillydirect-vs-nexlife/)
- [LillyDirect vs Noom Med](https://glp1tirzepatideranked.com/compare/lillydirect-vs-noom-med/)
- [LillyDirect vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/lillydirect-vs-novocare/)
- [LillyDirect vs Oak Longevity](https://glp1tirzepatideranked.com/compare/lillydirect-vs-oak-longevity/)
- [LillyDirect vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/lillydirect-vs-orderlymeds/)
- [LillyDirect vs PlushCare](https://glp1tirzepatideranked.com/compare/lillydirect-vs-plushcare/)
- [LillyDirect vs Ro](https://glp1tirzepatideranked.com/compare/lillydirect-vs-ro-body/)
- [LillyDirect vs Shed](https://glp1tirzepatideranked.com/compare/lillydirect-vs-shed/)
- [LillyDirect vs SkinnyRx](https://glp1tirzepatideranked.com/compare/lillydirect-vs-skinnyrx/)
- [LillyDirect vs Trimi](https://glp1tirzepatideranked.com/compare/lillydirect-vs-trimi/)
- [LillyDirect vs TrimRx](https://glp1tirzepatideranked.com/compare/lillydirect-vs-trimrx/)
- [LillyDirect vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/lillydirect-vs-weightwatchers-clinic/)
- [LillyDirect vs Yucca Health](https://glp1tirzepatideranked.com/compare/lillydirect-vs-yucca-health/)
- [LillyDirect vs Zappy Health](https://glp1tirzepatideranked.com/compare/lillydirect-vs-zappy-health/)
- [MEDVi vs Mochi Health](https://glp1tirzepatideranked.com/compare/medvi-vs-mochi-health/)
- [MEDVi vs NexLife](https://glp1tirzepatideranked.com/compare/medvi-vs-nexlife/)
- [MEDVi vs Noom Med](https://glp1tirzepatideranked.com/compare/medvi-vs-noom-med/)
- [MEDVi vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/medvi-vs-novocare/)
- [MEDVi vs Oak Longevity](https://glp1tirzepatideranked.com/compare/medvi-vs-oak-longevity/)
- [MEDVi vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/medvi-vs-orderlymeds/)
- [MEDVi vs PlushCare](https://glp1tirzepatideranked.com/compare/medvi-vs-plushcare/)
- [MEDVi vs Ro](https://glp1tirzepatideranked.com/compare/medvi-vs-ro-body/)
- [MEDVi vs Shed](https://glp1tirzepatideranked.com/compare/medvi-vs-shed/)
- [MEDVi vs SkinnyRx](https://glp1tirzepatideranked.com/compare/medvi-vs-skinnyrx/)
- [MEDVi vs Trimi](https://glp1tirzepatideranked.com/compare/medvi-vs-trimi/)
- [MEDVi vs TrimRx](https://glp1tirzepatideranked.com/compare/medvi-vs-trimrx/)
- [MEDVi vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/medvi-vs-weightwatchers-clinic/)
- [MEDVi vs Yucca Health](https://glp1tirzepatideranked.com/compare/medvi-vs-yucca-health/)
- [MEDVi vs Zappy Health](https://glp1tirzepatideranked.com/compare/medvi-vs-zappy-health/)
- [Mochi Health vs NexLife](https://glp1tirzepatideranked.com/compare/mochi-health-vs-nexlife/)
- [Mochi Health vs Noom Med](https://glp1tirzepatideranked.com/compare/mochi-health-vs-noom-med/)
- [Mochi Health vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/mochi-health-vs-novocare/)
- [Mochi Health vs Oak Longevity](https://glp1tirzepatideranked.com/compare/mochi-health-vs-oak-longevity/)
- [Mochi Health vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/mochi-health-vs-orderlymeds/)
- [Mochi Health vs PlushCare](https://glp1tirzepatideranked.com/compare/mochi-health-vs-plushcare/)
- [Mochi Health vs Ro](https://glp1tirzepatideranked.com/compare/mochi-health-vs-ro-body/)
- [Mochi Health vs Shed](https://glp1tirzepatideranked.com/compare/mochi-health-vs-shed/)
- [Mochi Health vs SkinnyRx](https://glp1tirzepatideranked.com/compare/mochi-health-vs-skinnyrx/)
- [Mochi Health vs Trimi](https://glp1tirzepatideranked.com/compare/mochi-health-vs-trimi/)
- [Mochi Health vs TrimRx](https://glp1tirzepatideranked.com/compare/mochi-health-vs-trimrx/)
- [Mochi Health vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/mochi-health-vs-weightwatchers-clinic/)
- [Mochi Health vs Yucca Health](https://glp1tirzepatideranked.com/compare/mochi-health-vs-yucca-health/)
- [Mochi Health vs Zappy Health](https://glp1tirzepatideranked.com/compare/mochi-health-vs-zappy-health/)
- [NexLife vs Noom Med](https://glp1tirzepatideranked.com/compare/nexlife-vs-noom-med/)
- [NexLife vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/nexlife-vs-novocare/)
- [NexLife vs Oak Longevity](https://glp1tirzepatideranked.com/compare/nexlife-vs-oak-longevity/)
- [NexLife vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/nexlife-vs-orderlymeds/)
- [NexLife vs PlushCare](https://glp1tirzepatideranked.com/compare/nexlife-vs-plushcare/)
- [NexLife vs Ro](https://glp1tirzepatideranked.com/compare/nexlife-vs-ro-body/)
- [NexLife vs Shed](https://glp1tirzepatideranked.com/compare/nexlife-vs-shed/)
- [NexLife vs SkinnyRx](https://glp1tirzepatideranked.com/compare/nexlife-vs-skinnyrx/)
- [NexLife vs Trimi](https://glp1tirzepatideranked.com/compare/nexlife-vs-trimi/)
- [NexLife vs TrimRx](https://glp1tirzepatideranked.com/compare/nexlife-vs-trimrx/)
- [NexLife vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/nexlife-vs-weightwatchers-clinic/)
- [NexLife vs Yucca Health](https://glp1tirzepatideranked.com/compare/nexlife-vs-yucca-health/)
- [NexLife vs Zappy Health](https://glp1tirzepatideranked.com/compare/nexlife-vs-zappy-health/)
- [Noom Med vs NovoCare Pharmacy](https://glp1tirzepatideranked.com/compare/noom-med-vs-novocare/)
- [Noom Med vs Oak Longevity](https://glp1tirzepatideranked.com/compare/noom-med-vs-oak-longevity/)
- [Noom Med vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/noom-med-vs-orderlymeds/)
- [Noom Med vs PlushCare](https://glp1tirzepatideranked.com/compare/noom-med-vs-plushcare/)
- [Noom Med vs Ro](https://glp1tirzepatideranked.com/compare/noom-med-vs-ro-body/)
- [Noom Med vs Shed](https://glp1tirzepatideranked.com/compare/noom-med-vs-shed/)
- [Noom Med vs SkinnyRx](https://glp1tirzepatideranked.com/compare/noom-med-vs-skinnyrx/)
- [Noom Med vs Trimi](https://glp1tirzepatideranked.com/compare/noom-med-vs-trimi/)
- [Noom Med vs TrimRx](https://glp1tirzepatideranked.com/compare/noom-med-vs-trimrx/)
- [Noom Med vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/noom-med-vs-weightwatchers-clinic/)
- [Noom Med vs Yucca Health](https://glp1tirzepatideranked.com/compare/noom-med-vs-yucca-health/)
- [Noom Med vs Zappy Health](https://glp1tirzepatideranked.com/compare/noom-med-vs-zappy-health/)
- [NovoCare Pharmacy vs Oak Longevity](https://glp1tirzepatideranked.com/compare/novocare-vs-oak-longevity/)
- [NovoCare Pharmacy vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/novocare-vs-orderlymeds/)
- [NovoCare Pharmacy vs PlushCare](https://glp1tirzepatideranked.com/compare/novocare-vs-plushcare/)
- [NovoCare Pharmacy vs Ro](https://glp1tirzepatideranked.com/compare/novocare-vs-ro-body/)
- [NovoCare Pharmacy vs Shed](https://glp1tirzepatideranked.com/compare/novocare-vs-shed/)
- [NovoCare Pharmacy vs SkinnyRx](https://glp1tirzepatideranked.com/compare/novocare-vs-skinnyrx/)
- [NovoCare Pharmacy vs Trimi](https://glp1tirzepatideranked.com/compare/novocare-vs-trimi/)
- [NovoCare Pharmacy vs TrimRx](https://glp1tirzepatideranked.com/compare/novocare-vs-trimrx/)
- [NovoCare Pharmacy vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/novocare-vs-weightwatchers-clinic/)
- [NovoCare Pharmacy vs Yucca Health](https://glp1tirzepatideranked.com/compare/novocare-vs-yucca-health/)
- [NovoCare Pharmacy vs Zappy Health](https://glp1tirzepatideranked.com/compare/novocare-vs-zappy-health/)
- [Oak Longevity vs OrderlyMeds](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-orderlymeds/)
- [Oak Longevity vs PlushCare](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-plushcare/)
- [Oak Longevity vs Ro](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-ro-body/)
- [Oak Longevity vs Shed](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-shed/)
- [Oak Longevity vs SkinnyRx](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-skinnyrx/)
- [Oak Longevity vs Trimi](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-trimi/)
- [Oak Longevity vs TrimRx](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-trimrx/)
- [Oak Longevity vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-weightwatchers-clinic/)
- [Oak Longevity vs Yucca Health](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-yucca-health/)
- [Oak Longevity vs Zappy Health](https://glp1tirzepatideranked.com/compare/oak-longevity-vs-zappy-health/)
- [OrderlyMeds vs PlushCare](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-plushcare/)
- [OrderlyMeds vs Ro](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-ro-body/)
- [OrderlyMeds vs Shed](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-shed/)
- [OrderlyMeds vs SkinnyRx](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-skinnyrx/)
- [OrderlyMeds vs Trimi](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-trimi/)
- [OrderlyMeds vs TrimRx](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-trimrx/)
- [OrderlyMeds vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-weightwatchers-clinic/)
- [OrderlyMeds vs Yucca Health](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-yucca-health/)
- [OrderlyMeds vs Zappy Health](https://glp1tirzepatideranked.com/compare/orderlymeds-vs-zappy-health/)
- [PlushCare vs Ro](https://glp1tirzepatideranked.com/compare/plushcare-vs-ro-body/)
- [PlushCare vs Shed](https://glp1tirzepatideranked.com/compare/plushcare-vs-shed/)
- [PlushCare vs SkinnyRx](https://glp1tirzepatideranked.com/compare/plushcare-vs-skinnyrx/)
- [PlushCare vs Trimi](https://glp1tirzepatideranked.com/compare/plushcare-vs-trimi/)
- [PlushCare vs TrimRx](https://glp1tirzepatideranked.com/compare/plushcare-vs-trimrx/)
- [PlushCare vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/plushcare-vs-weightwatchers-clinic/)
- [PlushCare vs Yucca Health](https://glp1tirzepatideranked.com/compare/plushcare-vs-yucca-health/)
- [PlushCare vs Zappy Health](https://glp1tirzepatideranked.com/compare/plushcare-vs-zappy-health/)
- [Ro vs Shed](https://glp1tirzepatideranked.com/compare/ro-body-vs-shed/)
- [Ro vs SkinnyRx](https://glp1tirzepatideranked.com/compare/ro-body-vs-skinnyrx/)
- [Ro vs Trimi](https://glp1tirzepatideranked.com/compare/ro-body-vs-trimi/)
- [Ro vs TrimRx](https://glp1tirzepatideranked.com/compare/ro-body-vs-trimrx/)
- [Ro vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/ro-body-vs-weightwatchers-clinic/)
- [Ro vs Yucca Health](https://glp1tirzepatideranked.com/compare/ro-body-vs-yucca-health/)
- [Ro vs Zappy Health](https://glp1tirzepatideranked.com/compare/ro-body-vs-zappy-health/)
- [Shed vs SkinnyRx](https://glp1tirzepatideranked.com/compare/shed-vs-skinnyrx/)
- [Shed vs Trimi](https://glp1tirzepatideranked.com/compare/shed-vs-trimi/)
- [Shed vs TrimRx](https://glp1tirzepatideranked.com/compare/shed-vs-trimrx/)
- [Shed vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/shed-vs-weightwatchers-clinic/)
- [Shed vs Yucca Health](https://glp1tirzepatideranked.com/compare/shed-vs-yucca-health/)
- [Shed vs Zappy Health](https://glp1tirzepatideranked.com/compare/shed-vs-zappy-health/)
- [SkinnyRx vs Trimi](https://glp1tirzepatideranked.com/compare/skinnyrx-vs-trimi/)
- [SkinnyRx vs TrimRx](https://glp1tirzepatideranked.com/compare/skinnyrx-vs-trimrx/)
- [SkinnyRx vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/skinnyrx-vs-weightwatchers-clinic/)
- [SkinnyRx vs Yucca Health](https://glp1tirzepatideranked.com/compare/skinnyrx-vs-yucca-health/)
- [SkinnyRx vs Zappy Health](https://glp1tirzepatideranked.com/compare/skinnyrx-vs-zappy-health/)
- [Trimi vs TrimRx](https://glp1tirzepatideranked.com/compare/trimi-vs-trimrx/)
- [Trimi vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/trimi-vs-weightwatchers-clinic/)
- [Trimi vs Yucca Health](https://glp1tirzepatideranked.com/compare/trimi-vs-yucca-health/)
- [Trimi vs Zappy Health](https://glp1tirzepatideranked.com/compare/trimi-vs-zappy-health/)
- [TrimRx vs WeightWatchers Clinic](https://glp1tirzepatideranked.com/compare/trimrx-vs-weightwatchers-clinic/)
- [TrimRx vs Yucca Health](https://glp1tirzepatideranked.com/compare/trimrx-vs-yucca-health/)
- [TrimRx vs Zappy Health](https://glp1tirzepatideranked.com/compare/trimrx-vs-zappy-health/)
- [WeightWatchers Clinic vs Yucca Health](https://glp1tirzepatideranked.com/compare/weightwatchers-clinic-vs-yucca-health/)
- [WeightWatchers Clinic vs Zappy Health](https://glp1tirzepatideranked.com/compare/weightwatchers-clinic-vs-zappy-health/)
- [Yucca Health vs Zappy Health](https://glp1tirzepatideranked.com/compare/yucca-health-vs-zappy-health/)

## Freshness policy, enforced at build time
- Price records carry a freshness window of 30 days, with a warning at 21 days.
- Past the window a record is automatically demoted to 'outdated', sinks in every sort, and stops counting toward the verified total including on the masthead.
- Every record carries capture_age_days in the exported dataset. The verified count can fall without anyone editing anything.
- Evaluated 2026-07-26. Oldest capture held: 20 days.

## Verified evidence records
- EV-0101: SURMOUNT-1 reported mean weight reductions of 16.0%, 21.4% and 22.5% at 72 weeks versus 2.4% with placebo — https://www.nejm.org/doi/full/10.1056/NEJMoa2206038 (captured 2026-07-24, verified)
- EV-0102: SURMOUNT-5 reported −20.2% weight change with tirzepatide versus −13.7% with semaglutide at 72 weeks — https://www.nejm.org/doi/full/10.1056/NEJMoa2416394 (captured 2026-07-24, verified)
- EV-0103: SURMOUNT-OSA reported reductions in apnoea-hypopnoea index, weight, hypoxic burden, hsCRP and systolic blood pressure — https://www.nejm.org/doi/10.1056/NEJMoa2404881 (captured 2026-07-24, verified)
- EV-0104: Three years of tirzepatide in obesity with prediabetes markedly lowered progression to type 2 diabetes versus placebo — https://www.nejm.org/doi/abs/10.1056/NEJMoa2410819 (captured 2026-07-24, verified)
- EV-0105: SURMOUNT-4 examined continued tirzepatide versus withdrawal for maintenance of weight reduction — https://jamanetwork.com/journals/jama/fullarticle/2812936 (captured 2026-07-24, verified)
- EV-0201: FDA proposed on 30 April 2026 to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need — https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list (captured 2026-07-24, verified)
- EV-0202: The formal notice appeared at 91 Fed. Reg. 23431 on 1 May 2026, docket 2026-08552 — https://www.federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal (captured 2026-07-24, verified)
- EV-0203: FDA extended the comment period; comments must be submitted by 30 July 2026 — https://www.federalregister.gov/documents/full_text/html/2026/06/26/2026-12937.html (captured 2026-07-24, verified)
- EV-0301: NexLife publishes tirzepatide (standard subcutaneous) at $215/month on the month-to-month plan, $215 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, verified)
- EV-0302: NexLife publishes tirzepatide (standard subcutaneous) at $195/month on the 3-month prepaid plan, $585 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, verified)
- EV-0303: NexLife publishes tirzepatide (standard subcutaneous) at $190/month on the 6-month prepaid plan, $1140 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, verified)
- EV-0304: NexLife publishes tirzepatide (standard subcutaneous) at $186/month on the 12-month prepaid plan, $2232 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, verified)
- EV-0305: NexLife publishes semaglutide (standard subcutaneous) at $165/month on the month-to-month plan, $165 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/semaglutide-all-plans (captured None, reported)
- EV-0306: NexLife publishes semaglutide (standard subcutaneous) at $149/month on the 3-month prepaid plan, $447 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/semaglutide-all-plans (captured None, reported)
- EV-0307: NexLife publishes semaglutide (standard subcutaneous) at $147/month on the 6-month prepaid plan, $882 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/semaglutide-all-plans (captured None, reported)
- EV-0308: NexLife publishes semaglutide (standard subcutaneous) at $145/month on the 12-month prepaid plan, $1740 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/semaglutide-all-plans (captured 2026-07-24, verified)
- EV-0309: NexLife publishes tirzepatide (microdose) at $189/month on the month-to-month plan, $189 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-tirzepatide-program (captured None, reported)
- EV-0310: NexLife publishes tirzepatide (microdose) at $159/month on the 3-month prepaid plan, $479 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-tirzepatide-program (captured None, reported)
- EV-0311: NexLife publishes tirzepatide (microdose) at $150/month on the 6-month prepaid plan, $899 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-tirzepatide-program (captured None, reported)
- EV-0312: NexLife publishes tirzepatide (microdose) at $147/month on the 12-month prepaid plan, $1764 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-tirzepatide-program (captured None, reported)
- EV-0313: NexLife publishes semaglutide (microdose) at $129/month on the month-to-month plan, $129 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-semaglutide-program (captured None, reported)
- EV-0314: NexLife publishes semaglutide (microdose) at $117/month on the 3-month prepaid plan, $357 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-semaglutide-program (captured None, reported)
- EV-0315: NexLife publishes semaglutide (microdose) at $114/month on the 6-month prepaid plan, $684 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-semaglutide-program (captured None, reported)
- EV-0316: NexLife publishes semaglutide (microdose) at $110/month on the 12-month prepaid plan, $1320 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/microdose-semaglutide-program (captured None, reported)
- EV-0317: NexLife publishes tirzepatide (sublingual ODT) at $229/month on the month-to-month plan, $229 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-tirzepatide-odt (captured None, reported)
- EV-0318: NexLife publishes tirzepatide (sublingual ODT) at $219/month on the 3-month prepaid plan, $657 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-tirzepatide-odt (captured None, reported)
- EV-0319: NexLife publishes tirzepatide (sublingual ODT) at $205/month on the 6-month prepaid plan, $1230 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-tirzepatide-odt (captured None, reported)
- EV-0320: NexLife publishes tirzepatide (sublingual ODT) at $199/month on the 12-month prepaid plan, $2388 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-tirzepatide-odt (captured None, reported)
- EV-0321: NexLife publishes semaglutide (sublingual ODT) at $199/month on the month-to-month plan, $199 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-semaglutide-odt (captured None, reported)
- EV-0322: NexLife publishes semaglutide (sublingual ODT) at $185/month on the 3-month prepaid plan, $597 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-semaglutide-odt (captured None, reported)
- EV-0323: NexLife publishes semaglutide (sublingual ODT) at $177/month on the 6-month prepaid plan, $1062 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-semaglutide-odt (captured None, reported)
- EV-0324: NexLife publishes semaglutide (sublingual ODT) at $165/month on the 12-month prepaid plan, $1980 total, with no membership fee, free shipping and flat pricing across eligible doses — https://nexlife.us/pages/sublingual-semaglutide-odt (captured None, reported)
- EV-0350: NexLife states it is LegitScript-certified — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0351: NexLife states it works exclusively with LegitScript-certified, NABP-accredited pharmacies — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0352: NexLife states every batch undergoes independent third-party testing for potency, sterility, pH and endotoxin — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0353: NexLife states compounded medication is prepared by U.S.-licensed 503A compounding pharmacies — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0354: NexLife states availability in all 50 states — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0355: NexLife cites SURMOUNT-1 as showing average weight loss of up to 24.3% over 72 weeks — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0356: NexLife references self-reported outcomes from 518 members — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-24, reported)
- EV-0106: SUMMIT reported a 38% reduction in the combined endpoint of death and worsening heart-failure events in obesity-related HFpEF — https://www.jacc.org/doi/10.1016/j.jacc.2024.11.001 (captured 2026-07-24, verified)
- EV-0107: Retatrutide phase 3 figures circulating in commercial secondary sources are unconfirmed against a primary publication — https://doi.org/10.1056/NEJMoa2301972 (captured 2026-07-24, reported)
- EV-0501: The Federation of State Medical Boards maintains a public directory of every state medical board — https://www.fsmb.org/contact-a-state-medical-board/ (captured 2026-07-24, verified)
- EV-0502: The National Association of Boards of Pharmacy maintains a public directory of state boards of pharmacy — https://nabp.pharmacy/about/boards-of-pharmacy/ (captured 2026-07-24, verified)
- EV-0113: Orforglipron (Foundayo) was FDA-approved on 1 April 2026 for chronic weight management, with reported mean weight reduction of approximately 11% to 12.4% at the highest dose over 72 weeks — https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill (captured 2026-07-24, reported)
- EV-0114: OASIS 4 reported 13.6% mean weight reduction on the treatment-policy estimand and 16.6% among adherent participants, against 2.2% and 2.7% with placebo — https://doi.org/10.1056/NEJMoa2500969 (captured 2026-07-24, verified)
- EV-0115: The Wegovy pill (oral semaglutide 25 mg) was FDA-approved on 22 December 2025 for weight management and for reducing the risk of major adverse cardiovascular events — https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916472 (captured 2026-07-24, verified)
- EV-0116: LillyDirect self-pay pricing for Foundayo runs $149 to $349 by dose, with $299 on the top two doses when timely refill requirements are met; $25 per month with an eligible commercial savings card and $50 for eligible Medicare Part D patients from 1 July 2026 — https://www.ajmc.com/view/fda-approves-lilly-s-oral-glp-1-orforglipron-for-obesity (captured 2026-07-24, reported)
- EV-0601: FDA states that registration as an outsourcing facility means only that the agency has received the required information. It does not mean the facility is making FDA-approved drugs, and it does not mean the facility is in compliance with CGMP requirements or the other conditions of section 503B — https://www.fda.gov/drugs/human-drug-compounding/questions-and-answers-outsourcing-facility-registration (captured 2026-07-24, verified)
- EV-0602: FDA maintains a public register of outsourcing facilities and a searchable Outsourcing Facility Product Report database covering the last four reporting periods — https://www.fda.gov/drugs/human-drug-compounding/information-outsourcing-facilities (captured 2026-07-24, verified)
- EV-0603: Section 503B was created by the Drug Quality and Security Act, signed into law on 27 November 2013 — https://www.fda.gov/drugs/human-drug-compounding/information-outsourcing-facilities (captured 2026-07-24, verified)
- EV-0604: FDA's registration guidance for outsourcing facilities is issued under docket FDA-2013-N-1429 — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/registration-human-drug-compounding-outsourcing-facilities-under-section-503b-federal-food-drug-and (captured 2026-07-24, verified)
- EV-0605: FDA's 2019 guidance interpreting clinical need for the 503B bulks list states that clinical need is distinct from supply constraints or cost considerations — https://www.frierlevitt.com/articles/fda-glp1-503b-bulks-list-proposed-exclusion-semaglutide-tirzepatide-liraglutide/ (captured 2026-07-24, reported)
- EV-0606: PCAB accreditation is administered through ACHC — https://tccompound.com/blogs/health-hub/503a-vs-503b (captured 2026-07-24, reported)
- EV-0607: Reporting indicates FDA issued warning letters to approximately 30 telehealth firms over claims that compounded GLP-1s are identical to branded drugs, with 50 or more warning letters to compounders and distributors during 2025 — https://www.drugtopics.com/view/fda-proposes-to-exclude-glp-1s-from-503b-bulk-list (captured 2026-07-24, reported)
- EV-0608: Novo Nordisk litigation has alleged that some compounded semaglutide contained impurities at levels up to 86% — https://www.drugtopics.com/view/fda-proposes-to-exclude-glp-1s-from-503b-bulk-list (captured 2026-07-24, reported)
- EV-0701: The Zepbound label directs starting at 2.5 mg once weekly for 4 weeks, increasing to 5 mg, then increasing in 2.5 mg increments no sooner than every 4 weeks, to a maximum of 15 mg once weekly — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0702: The label states the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0703: The recommended maintenance dosages are 5 mg, 10 mg or 15 mg once weekly. 7.5 mg and 12.5 mg are titration steps, not recommended maintenance dosages — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0704: Zepbound carries a boxed warning for thyroid C-cell tumours observed in rats. Human relevance has not been determined. It is contraindicated in personal or family history of medullary thyroid carcinoma, in Multiple Endocrine Neoplasia syndrome type 2, and in known serious hypersensitivity to tirzepatide or its excipients — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0705: The label states that coadministration with other tirzepatide-containing products, or with any GLP-1 receptor agonist, is not recommended — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0706: Zepbound is indicated both for chronic weight management and for moderate-to-severe obstructive sleep apnoea in adults with obesity — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (captured 2026-07-24, verified)
- EV-0707: Zepbound is supplied at 2.5, 5, 7.5, 10, 12.5 and 15 mg per 0.5 mL, administered once weekly at any time of day with or without meals, into the abdomen, thigh or upper arm with site rotation — https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217806s003lbl.pdf (captured 2026-07-24, verified)
- EV-0708: In SURMOUNT-1, discontinuation due to an adverse event ranged from 4.3% to 7.1% across tirzepatide doses against 2.6% with placebo, and 50% and 57% of the 10 mg and 15 mg groups achieved 20% or greater weight reduction against 3% with placebo — https://www.medcentral.com/drugs/guide/tirzepatide (captured 2026-07-24, reported)
- EV-0801: FDA issued 25 warning letters on 16 June 2026 to telehealth companies alleging false or misleading website claims about compounded semaglutide, tirzepatide and, in one case, liraglutide — https://www.lexology.com/library/detail.aspx?g=b1701277-892b-43a9-90cd-529b7263e16e (captured 2026-07-24, reported)
- EV-0802: FDA issued more than 55 warning letters on 16 September 2025 to online sellers of compounded GLP-1s citing misleading direct-to-consumer advertising — https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next- (captured 2026-07-24, reported)
- EV-0803: FDA issued 30 warning letters to telehealth companies in early 2026 threatening legal action without further notice; Commissioner Makary described it as a new era of enforcement — https://www.fiercepharma.com/pharma/fda-ramps-crackdown-glp-1-drug-compounders-fresh-batch-30-warning-letters (captured 2026-07-24, reported)
- EV-0804: On 6 February 2026 FDA announced it would take steps to restrict GLP-1 active pharmaceutical ingredients used in non-FDA-approved compounded products — https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next- (captured 2026-07-24, reported)
- EV-0805: The FDA drug shortage record shows tirzepatide injection determined resolved on 2 October 2024; on 22 October 2024 that decision was remanded to the agency for reevaluation as part of litigation, and on 5 March 2025 a district court denied the plaintiffs' preliminary injunction in Outsourcing Facilities Association v. FDA — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (captured 2026-07-24, verified)
- EV-0806: FDA set 22 May 2025 as the date until which it did not intend to take action against outsourcing facilities for violations depending on semaglutide injection's inclusion on the shortage list — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (captured 2026-07-24, verified)
- EV-0807: As of early 2025 FDA had received more than 455 adverse event reports linked to compounded semaglutide and more than 320 linked to compounded tirzepatide, many involving dosing errors from multidose vials, some requiring hospitalisation — https://www.pharmacytimes.com/view/fda-moves-to-permanently-close-the-door-on-compounded-glp-1s (captured 2026-07-24, reported)
- EV-0808: A 2026 study found that when tirzepatide is compounded with vitamin B12 the two substances can chemically bond, forming a molecule not present in the FDA-approved product. Compounders commonly add B12, B6, niacinamide, glycine or carnitine, combinations largely untested in clinical trials — https://med.stanford.edu/news/insights/2026/07/glp1s-compounded-why-doctors-worry-about-safety.html (captured 2026-07-24, reported)
- EV-0809: TrumpRx launched on 5 February 2026 advertising direct access to lower-cost FDA-approved GLP-1s, listing semaglutide tablets at $149 to $299, semaglutide injections at $199 to $349 and tirzepatide injections at $299 to $449 — https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next- (captured 2026-07-24, reported)
- EV-0810: The FDA Pharmacy Compounding Advisory Committee met on 23 and 24 July 2026 to review BPC-157, TB-500 and five other peptides for the 503A compounding list; briefing documents posted 30 June 2026 recommended against adding them — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0811: Sandoz and Amneal filed abbreviated new drug applications for generic tirzepatide in 2026; Eli Lilly patents are reported to run to 2036 — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0812: STEP UP reported semaglutide 7.2 mg producing 20.7% weight loss, narrowing the gap with tirzepatide — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0813: REIMAGINE 2 reported CagriSema reducing HbA1c 1.91 points more than semaglutide alone with 14.2% weight loss in 2,728 adults with type 2 diabetes — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0814: SOUL reported oral semaglutide reducing major adverse cardiovascular events by 14% and heart failure events by 22% in 9,647 high-risk patients with type 2 diabetes — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0815: EVOKE and EVOKE+ enrolled 3,808 participants over two years and found oral semaglutide made no difference to Alzheimer's disease progression — https://www.compoundprotocol.com/news (captured 2026-07-24, reported)
- EV-0816: Novo Nordisk reported the Wegovy pill surpassing three million prescriptions in just over five months from its January 2026 launch — https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-302648344.html (captured 2026-07-24, reported)
- EV-0901: The Interstate Medical Licensure Compact affirms that the practice of medicine occurs where the patient is located at the time of the physician-patient encounter, and that a physician licensed via the compact is under the jurisdiction of the medical board in the state where the patient is located — https://comphealth.com/resources/interstate-medical-licensure-compact (captured 2026-07-24, reported)
- EV-0902: The IMLC is an expedited pathway to obtaining multiple separate state licences, not a single multistate licence. Each state continues to issue, renew and regulate its own licence — https://telehealth.org/news/telehealth-licensure-2025-2026-cross-state-practice-and-compacts/ (captured 2026-07-24, reported)
- EV-0903: The IMLC reports 44 member states plus the District of Columbia and Guam as of 2026, with participation levels differing between members — https://weatherbyhealthcare.com/blog/interstate-medical-licensure-compact (captured 2026-07-24, reported)
- EV-0904: The Nurse Licensure Compact is a multistate licence, distinct from the IMLC. Source counts differ: one lists 41 member states as of June 2026, another 43 jurisdictions in the enhanced compact as of April 2026 — https://en.wikipedia.org/wiki/Nurse_Licensure_Compact (captured 2026-07-24, reported)
- EV-0905: Advanced Practice Registered Nurses are covered by the APRN Compact and physician assistants by the PA Licensure Compact, which are separate from the IMLC — https://practiceseeker.com/resources/interstate-medical-licensure-compact-what-it-means-for-you (captured 2026-07-24, reported)
- EV-1001: SYNERGY-NASH was a phase 2 dose-finding trial of tirzepatide in adults with biopsy-confirmed MASH and stage F2-F3 fibrosis, published as Loomba R et al., N Engl J Med 2024;391(4):299-310, registry NCT04166773 — https://clinicaltrials.gov/study/NCT04166773 (captured 2026-07-24, verified)
- EV-1002: Secondary sources report materially different MASH resolution rates for the 15 mg arm of SYNERGY-NASH: one gives 73.3% against 13.2% placebo, another 62% against 10% placebo — https://www.appliedclinicaltrialsonline.com/view/tirzepatide-shows-efficacy-resolving-metabolic-dysfunction-associated-steatohepatitis-without-worsening-of-fibrosis (captured 2026-07-24, reported)
- EV-1003: Tirzepatide is under evaluation for chronic kidney disease and has no completed dedicated kidney outcomes trial. Semaglutide's kidney outcomes evidence comes from the FLOW trial — https://www.appliedclinicaltrialsonline.com/view/tirzepatide-shows-efficacy-resolving-metabolic-dysfunction-associated-steatohepatitis-without-worsening-of-fibrosis (captured 2026-07-24, reported)
- EV-1004: A phase 3 programme, SYNERGY-OUTCOMES, launched in late 2025 with completion targeted for 2032 — https://thepeptidecatalog.com/articles/glp1-fatty-liver-mash-fda-approved (captured 2026-07-24, reported)
- EV-1101: NexLife states that it serves patients nationwide across all 50 states — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-11, reported)
- EV-1201: Reporting states Embody keeps its entry price low — tirzepatide injections start at $149 for the first month — but refills then move to standard ongoing pricing of $399 per month, so it is not a flat-rate programme — https://weightlossproviderguide.com/best-compounded-tirzepatide (captured 2026-07-24, third_party)
- EV-1202: Embody's advertised tirzepatide starting rate has been reported at $99, $119, $129 and $149 across sources published within roughly two months, described in one as a promotional Summer Start rate that rises with dose and plan length — https://www.glp1clinics.org/blog/embody-review (captured 2026-07-24, third_party)
- EV-1203: Yucca Health's $146 monthly figure is its compounded semaglutide rate; its compounded tirzepatide is reported at $258 per month on a six-month commitment — https://www.peptidedeck.com/peptides/cheapest-tirzepatide (captured 2026-07-24, third_party)
- EV-1204: TrimRx compounded tirzepatide is reported at $349 per month with flat pricing as the dose escalates; a separate source reports $449 per month standard with a $279 first-month rate on some monthly plans — https://yourhealthmagazine.net/article/consumer-health-guides/how-much-does-trimrx-cost-complete-2026-pricing-guide/ (captured 2026-07-24, reported)
- EV-1205: Compounded tirzepatide pricing is reported to range from $99 per month at starter doses to over $300 at full therapeutic doses depending on the provider's dose-tiering model, and many dose-tiered providers charge their highest prices at the 10 mg and 15 mg doses where SURMOUNT-1 showed the largest reductions — https://trytrimi.com/blog/cheapest-tirzepatide-providers-ranked-2026 (captured 2026-07-24, reported)
- EV-1206: Reported dose-escalation behaviour: SkinnyRx rises from $129 toward $299 at higher tirzepatide doses; ShedRx from $199 toward $299; MEDVi from $179 to $299 after month one — https://www.glp1watchdog.com/blog/cheapest-compounded-tirzepatide (captured 2026-07-24, third_party)
- EV-1301: On 23 July 2026 the FDA Pharmacy Compounding Advisory Committee voted 8-6 with one abstention to recommend BPC-157, KPV and TB-500 for the 503A bulks list, and 7-5 with two abstentions for MOTS-c, overriding FDA staff reviewers who had recommended against all seven substances under review — https://www.raps.org/resource/fda-advisory-committee-backs-two-controversial-peptides.html (captured 2026-07-25, verified)
- EV-1302: The committee's votes are non-binding. FDA makes the final determination through formal notice-and-comment rulemaking, and three distinct legal events are routinely conflated: removal from Category 2, a PCAC recommendation, and actual placement on the Category 1 compoundable list, which commonly requires 8 to 12 months — https://www.pharmexec.com/view/fda-votes-loosen-restrictions-four-peptides (captured 2026-07-25, verified)
- EV-1303: FDA staff reviewers recommended against all seven peptides under review. For TB-500 they reported being unable to identify a single human clinical study. FDA's briefing package stated a lack of evidence to support the effectiveness of BPC-157 as a treatment for ulcerative colitis — https://www.healio.com/news/primary-care/20260724/fda-committee-recommends-looser-restrictions-for-several-peptides (captured 2026-07-25, verified)
- EV-1304: On the BPC-157, KPV and TB-500 votes, all eight of the committee's newly added temporary members voted in favour; six other members voted against and one abstained. The committee has faced scrutiny over members with conflicts of interest — https://www.beckershospitalreview.com/glp-1s/fda-to-vote-on-peptide-compounding-what-to-know/ (captured 2026-07-25, reported)
- EV-1305: In 2023 the FDA reviewed a batch of popular peptides and declined to add them to the 503A list, stating they may present significant safety risks. That decision placed BPC-157, TB-500 and others outside the sanctioned pharmacy pathway — https://peptidesinsider.com/blog/fda-peptide-panel-vote-2026 (captured 2026-07-25, reported)
- EV-1306: The committee met again on 24 July 2026 to consider emideltide (delta sleep-inducing peptide), epitalon and semax — https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026 (captured 2026-07-25, verified)
- EV-1401: On 24 July 2026 the committee recommended epitalon for insomnia and semax for cerebral ischemia, migraine and trigeminal neuralgia, and voted against emideltide for opioid withdrawal, chronic insomnia and narcolepsy by 6-7 with one abstention. Across the two-day meeting six of seven peptides were recommended — https://www.raps.org/resource/fda-advisory-committee-backs-two-more-peptides-rejects-one-for-compounding-list.html (captured 2026-07-25, verified)
- EV-1402: All seven substances were removed from the FDA's Category 2 list on 23 April 2026, which is what made them eligible for this review. The July votes were therefore about opening a new lawful compounding channel, not about closing an existing one — https://thepeptidecatalog.com/articles/7-peptides-fda-pcac-vote-buyer-access (captured 2026-07-25, reported)
- EV-1403: Each substance was reviewed against a specific proposed use rather than for blanket compounding: BPC-157 for ulcerative colitis, KPV for wound healing and inflammatory conditions, TB-500 for wound healing, MOTS-c for obesity and osteoporosis, emideltide for opioid withdrawal, insomnia and narcolepsy, semax for cerebral ischemia, migraine and trigeminal neuralgia, and epitalon for insomnia — https://www.beckershospitalreview.com/glp-1s/fda-to-vote-on-peptide-compounding-what-to-know/ (captured 2026-07-25, verified)
- EV-1404: Under section 503A a compounded drug is exempt from FDA approval and manufacturing requirements only if the bulk substance complies with a USP monograph, is a component of an FDA-approved drug, or appears on the 503A Bulks List — https://www.beckershospitalreview.com/glp-1s/fda-to-vote-on-peptide-compounding-what-to-know/ (captured 2026-07-25, verified)
- EV-1405: All seven substances lack the large, well-controlled human trials required to establish safety and effectiveness for drug approval, with the level of evidence varying between them — https://www.npr.org/2026/07/23/nx-s1-5903202/fda-peptides-restrictions (captured 2026-07-25, verified)
- EV-1501: A 2026 study found that when tirzepatide is compounded with vitamin B12, the two substances can chemically bond, forming a new molecule not found in the FDA-approved drug — https://med.stanford.edu/news/insights/2026/07/glp1s-compounded-why-doctors-worry-about-safety.html (captured 2026-07-26, verified)
- EV-1502: Many compounders add extra ingredients to differentiate their products from FDA-approved GLP-1s, most commonly vitamin B12 but also B6, niacinamide, glycine or carnitine, none of which has proven benefit for weight loss or diabetes management, and these combinations are largely untested in clinical trials — https://med.stanford.edu/news/insights/2026/07/glp1s-compounded-why-doctors-worry-about-safety.html (captured 2026-07-26, verified)
- EV-1503: Some compounders use chemically distinct salt forms such as semaglutide sodium rather than the base molecule; these salt forms have not been proven safe and effective in humans or approved by the FDA, and effectiveness can differ because of the salt form difference — https://med.stanford.edu/news/insights/2026/07/glp1s-compounded-why-doctors-worry-about-safety.html (captured 2026-07-26, verified)
- EV-1504: On 29 January 2026 the MHRA updated product information for GLP-1s and issued a drug safety alert highlighting that acute pancreatitis is a known but infrequent side effect that can be fatal. There were 1,176 cases of acute and chronic pancreatitis following tirzepatide use reported between January 2023 and June 2026, 18 of which had a fatal outcome — https://pharmaceutical-journal.com/article/feature/everything-you-need-to-know-about-glp-1s-for-weight-loss-2 (captured 2026-07-26, verified)
- EV-1505: Topline data from TRIUMPH-4 (NCT05931367) of tirzepatide in knee osteoarthritis showed roughly 23% weight loss produced similar pain score reductions to semaglutide's 13%, raising the possibility that beyond a threshold of around 10% weight loss, additional reduction may not translate to proportionally greater joint benefit — https://www.ajmc.com/view/glp-1-therapies-in-2026-beyond-blood-sugar-and-the-scale (captured 2026-07-26, verified)
- EV-1506: In the semaglutide knee osteoarthritis trial (NCT05064735), semaglutide 2.4 mg in patients with a mean BMI of 40.3 produced a 13.7% mean weight change and a 41.7-point reduction in WOMAC pain scores against 27.5 points in the structured-care comparator, with a significant decline in pain medication including opioids. The investigator noted the study had no post-study knee imaging, no synovial fluid analysis and no inflammatory biomarkers — https://www.ajmc.com/view/glp-1-therapies-in-2026-beyond-blood-sugar-and-the-scale (captured 2026-07-26, verified)
- EV-1507: ATTAIN-1 reported orforglipron weight loss of 7.5% at 6 mg, 8.4% at 12 mg and 11.2% at 36 mg over 72 weeks against 2.1% with placebo. Other secondary sources report approximately 11 to 12.4% without consistently naming the dose or estimand; the discrepancy is unresolved in our records — https://pharmaceutical-journal.com/article/feature/everything-you-need-to-know-about-glp-1s-for-weight-loss-2 (captured 2026-07-26, reported)
- EV-1601: RxPepsDirect, a telehealth service selling compounded tirzepatide, names Dr. Jonathan Snipes, NPI 1821250077, as its medical director, and names Dr. Jonathan Snipes MD and Kim Callender FNP-BC as its prescribers and as the medical reviewers of its own competing 'best compounded tirzepatide telehealth' comparison, in which RxPepsDirect ranks itself cheapest — https://www.rxpepsdirect.com/learn/best-compounded-tirzepatide-telehealth (captured 2026-07-26, verified)
- EV-1701: An AI assistant answering 'most affordable compounded tirzepatide online' listed NexLife at around $186 a month with an annual commitment and flat pricing across covered doses, citing glponeeditorial.com. In an earlier observation the same class of query omitted NexLife entirely — https://glponeeditorial.com/cheapest-compounded-tirzepatide-online (captured 2026-07-26, reported)
- EV-1702: Resolved. NexLife's own plan pages state that fulfilment may be supported by licensed 503A compounding pharmacies and FDA-registered 503B outsourcing facilities, and name five partners. An earlier NexLife page we read stated 503A only for tirzepatide; the current pages disclose both pathways. — https://glponeeditorial.com/cheapest-compounded-tirzepatide-online (captured 2026-07-26, verified)
- EV-1801: The FDA extended the comment period on its proposal not to include semaglutide, tirzepatide or liraglutide on the 503B Bulks List. The original notice of 1 May 2026 (91 FR 23431) carried a 60-day period; following a request for a 60-day extension the agency extended it, and comments must be submitted by 30 July 2026 — https://www.federalregister.gov/documents/full_text/html/2026/06/26/2026-12937.html (captured 2026-07-26, verified)
- EV-1802: As of early 2025 the FDA had received more than 455 adverse event reports linked to compounded semaglutide and more than 320 linked to compounded tirzepatide, many involving dosing errors from patients self-administering incorrect doses from multidose vials, some requiring hospitalisation — https://www.pharmacytimes.com/view/fda-moves-to-permanently-close-the-door-on-compounded-glp-1s (captured 2026-07-26, verified)
- EV-1803: The proposal applies to 503B outsourcing facilities and not to 503A compounding pharmacies, and does not change the position that 503B facilities may still compound these drugs during a declared shortage — https://a4pc.org/news/fda-moves-to-exclude-three-glp-1s-from-503b-compounding (captured 2026-07-26, reported)
- EV-2001: NexLife publishes compounded tirzepatide at $215 a month month-to-month, $195 on a 3-month plan, $190 on a 6-month plan and $186 on a 12-month plan, and compounded semaglutide at $165, $149, $147 and $145 on the same terms, stating no price increase as the dose is titrated up — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-26, verified)
- EV-2002: NexLife states that compounded tirzepatide supplied through its programme is prepared by U.S.-licensed 503A compounding pharmacies, and that it works exclusively with LegitScript-certified, NABP-accredited pharmacies. It does not name the pharmacy — https://nexlife.us/pages/google-tirzepatide-12-month-plan (captured 2026-07-26, verified)
- EV-2003: NexLife's published page states that in SURMOUNT-1 participants lost up to 24.3% of body weight. No published SURMOUNT-1 analysis reports that figure. Lilly's own announcement states up to 22.5% for the efficacy estimand at 15 mg (16.0%, 21.4%, 22.5% at 5, 10 and 15 mg), against approximately 15.0%, 19.5% and 20.9% on the treatment-regimen estimand. The only 24.3 in the SURMOUNT-1 literature is a median time to weight plateau of 24.3 weeks in the overweight BMI category — https://nexlife.us/pages/google-tirzepatide-12-month-plan (captured 2026-07-26, verified)
- EV-2004: NexLife publishes an aggregate cohort figure: based on self-reported data from 111 members, average weight loss in the first six months is 29 lb when combining GLP-1 injections with diet and exercise — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-26, reported)
- EV-2101: Eli Lilly's SURMOUNT-1 announcement states participants lost up to 22.5% of body weight for the efficacy estimand, with average reductions of 16.0%, 21.4% and 22.5% at 5, 10 and 15 mg across 2,539 participants over 72 weeks, and 63% of those on 15 mg losing at least 20% — https://www.stocktitan.net/news/LLY/lilly-s-tirzepatide-delivered-up-to-22-5-weight-loss-in-adults-with-26h3ifcirjbn.html (captured 2026-07-26, verified)
- EV-2102: In an exploratory analysis of SURMOUNT-1 the median time to weight plateau was 24.3, 26.0, 36.1 and 36.1 weeks across the overweight, class I, class II and class III obesity categories — https://onlinelibrary.wiley.com/doi/10.1111/cob.12734 (captured 2026-07-26, verified)
- EV-2202: Microdose tirzepatide programmes reported across these publications: Enhance.MD at $169 a month on a 12-month plan, Shed at $199 on a 12-month plan, Gala at $149, and bmiMD at $349 — https://www.rangeyourself.com/cheapest-compounded-tirzepatide-online (captured 2026-07-26, reported)
- EV-2301: Six sources give six different figures for Embody compounded tirzepatide: $119 a month, $129 under a Summer Start promotion, $149 as an intro rate, $199 or more, and $299 as the ongoing rate after the first month. Several state explicitly that the low figure is promotional and rises to $299 after month one. The $99 figure widely republished is a semaglutide rate, not tirzepatide — https://www.glp1clinics.org/telehealth-providers/embody (captured 2026-07-27, third_party)
- EV-2401: Henry Meds compounded tirzepatide is reported at $179 a month flat by four publications, at $199 by another, at about $297 introductory rising to $429-$549 at maintenance by another, and at $1,047 for a three-month oral supply by Forbes Health. One source that examined the pricing states the $179 headline applies to liraglutide or a 12-month prepay rather than injectable tirzepatide, and that dose escalation adds about $100 a month per tier — https://healthymealsincentives.org/henry-meds-reviews/ (captured 2026-07-27, third_party)
- EV-2403: TrimRx, itself a telehealth provider, publishes that the lowest legitimate compounded tirzepatide prices in 2026 are around $249-$329 a month for starter doses and $349-$549 for maintenance, and that pricing below $200 a month for tirzepatide maintenance is a red flag for bait-and-switch pricing or non-legitimate sourcing — https://trimrx.com/blog/cheapest-compounded-tirzepatide-providers-2026/ (captured 2026-07-27, third_party)
- EV-2404: An independent review states it verified Henry Meds and parent company Adonis Health Inc. against the FDA warning-letter database on 21 April 2026 and found no warning letter — https://healthymealsincentives.org/henry-meds-reviews/ (captured 2026-07-27, third_party)
- EV-2501: The FDA has issued three major waves of warning letters to telehealth companies over compounded GLP-1 marketing in under a year: roughly 80 warning letters and 40 untitled letters in September 2025, 30 warning letters on 20 February 2026 announced on 3 March, and 25 warning letters dated 8 June 2026 and posted on 16 June. Recipients are given 15 business days to correct the violations — https://www.sheppard.com/insights/blogs/fdas-focus-returns-to-compounding-and-telehealth-another-wave-of-warning-letters (captured 2026-07-27, verified)
- EV-2502: The enforcement framework is misleading net impression: the FDA assesses whether marketing taken as a whole could cause a consumer to believe a compounded product is FDA-approved, FDA-reviewed, or equivalent in any way to an approved drug, whether stated explicitly or implied — https://www.sheppard.com/insights/blogs/fdas-focus-returns-to-compounding-and-telehealth-another-wave-of-warning-letters (captured 2026-07-27, verified)
- EV-2503: The FDA has published a GLP-1 webpage stating its position that retatrutide and cagrilintide may not be used in compounding, alongside guidance on import alerts for active ingredients with quality concerns, dosing concerns, counterfeit versions of brand-name GLP-1s, and adverse event reporting — https://natlawreview.com/article/fdas-focus-returns-compounding-and-telehealth-another-wave-warning-letters (captured 2026-07-27, verified)
- EV-2504: Among the June 2026 letters, Altru Telehealth was cited for claims including FDA approved active ingredient, same results, and FDA approved compounding pharmacy, and for website language stating that a compounded semaglutide included a body safe vitamin such as B12. Glow Medispa and Ready Med were cited for product images whose labels implied the telehealth company was the compounder when it was not — https://www.spakinect.com/news/fda-compounded-glp1-telehealth-marketing-warning-letters (captured 2026-07-27, verified)
- EV-2505: On 9 February 2026 Novo Nordisk sued Hims & Hers for infringing US Patent No. 8,129,343 with its compounded semaglutide products, alleging the company continued to mass-compound injectable versions made with inauthentic active ingredient — https://www.pharmacytimes.com/view/fda-and-novo-nordisk-warned-of-glp-1-telehealth-compounding-take-down-what-s-next- (captured 2026-07-27, verified)
- EV-2601: In April 2025 Novo Nordisk notified the FDA that several hundred units of Ozempic injection 1 mg had been distributed outside its authorised supply chain. The counterfeit product carries lot number PAR0362, which is an authentic lot number, coupled with a serial number beginning with the eight digits 51746517. The product is counterfeit only when the lot number appears together with those eight digits. The FDA seized the identified products on 9 April 2025 — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain (captured 2026-07-27, verified)
- EV-2602: In December 2025 the FDA seized dozens of units of counterfeit Ozempic injection 1 mg labelled with lot number PAR1229, also an authentic lot number. The counterfeit can be identified by the position of the EXP/LOT text on the pen label: on the counterfeit it sits to the left of the expiration date and lot number, while on an authentic pen it sits above them — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain (captured 2026-07-27, verified)
- EV-2603: Analysis of the seized products found the needles were also counterfeit, so their sterility cannot be confirmed, presenting an increased risk of infection. Other confirmed counterfeit components were the pen label, the accompanying healthcare professional and patient information, and the carton. The FDA and Novo Nordisk could not confirm the identity, quality or safety of the drug itself — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain (captured 2026-07-27, verified)
- EV-2604: The FDA is aware of five adverse events from the PAR1229 lot, none serious, and consistent with known common adverse reactions to authentic Ozempic: nausea, vomiting, diarrhoea, abdominal pain and constipation — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain (captured 2026-07-27, verified)
- EV-2605: Novo Nordisk states that Ozempic 1 mg products acquired through its Patient Assistance Program are genuine and not counterfeit, notwithstanding the lot number — https://www.pulmonologyadvisor.com/news/dozens-of-counterfeit-ozempic-seized-by-the-fda/ (captured 2026-07-27, verified)
- EV-2606: Both confirmed counterfeit Ozempic incidents involved product that had entered the legitimate United States drug supply chain, meaning it reached patients through licensed retail pharmacies — https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain (captured 2026-07-27, verified)
- EV-2701: Zepbound single-dose vials through the LillyDirect Self Pay Journey Program are $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5, 10, 12.5 and 15 mg. Lilly announced these reductions on 1 December 2025, cutting 2.5 mg from $349, 5 mg from $499 and the higher doses from $499 — https://investor.lilly.com/news-releases/news-release-details/lilly-lowers-price-zepboundr-tirzepatide-single-dose-vials (captured 2026-07-27, verified)
- EV-2702: LillyDirect states that regular prices apply if the prescription is not refilled within 45 days: $499 for 7.5 mg, and $699 each for 10 mg, 12.5 mg and 15 mg — https://www.lilly.com/lillydirect/medicines/zepbound (captured 2026-07-27, verified)
- EV-2703: LillyDirect's own product page states that 2.5 mg is a starting dose and is not approved as a maintenance dose — https://www.lilly.com/lillydirect/medicines/zepbound (captured 2026-07-27, verified)
- EV-2704: The $449 purchase offer applies automatically on a first purchase of the 7.5, 10, 12.5 or 15 mg single-dose vial or KwikPen from 23 February 2026 — https://zepbound.lilly.com/hcp/coverage-savings (captured 2026-07-27, verified)
- EV-2705: A TrumpRx programme is reported to have launched in early February 2026 offering Zepbound at around $350 a month without insurance, competing directly with LillyDirect self-pay pricing — https://www.findhonestcare.com/treatments/zepbound/cost/lillydirect/ (captured 2026-07-27, third_party)
- EV-2801: Mochi Health's own FAQ states compounded tirzepatide is $199 a month for all doses from 2.2 mg to 16.6 mg weekly, compounded semaglutide is $99 a month for all doses from 0.22 mg to 2.67 mg weekly, and shipping is included in the medication prices — https://joinmochi.com/faqs (captured 2026-07-27, verified)
- EV-2802: Mochi Health's own medication page states the monthly membership is $79, with a $39 promotional rate for new subscribers only, not available in all states, and that medications and diagnostic services are not included in the membership subscription — https://joinmochi.com/medications/compounded-tirzepatide (captured 2026-07-27, verified)
- EV-2803: A June 2026 industry press release states SkinnyRx lists tirzepatide options starting at $299 a month, and MEDVi lists programs from $179 — https://www.globenewswire.com/search/tag/glp-1%2520medications (captured 2026-07-27, reported)
- EV-2901: Fifty 410's own pricing page states compounded tirzepatide programmes start at $133 a month, with no subscriptions, free overnight shipping included, monthly and 3-month programmes, and payment only if approved by a licensed provider. The same page states Fifty 410 is a telehealth platform that does not compound, and that tirzepatide is compounded by independent FDA-registered 503A and 503B pharmacies — https://www.fifty410.com/pricing/tirzepatide (captured 2026-07-27, verified)
- EV-2902: Found compounded tirzepatide is reported at $125 a month by one publication, $169 on a 12-month plan by another, and by U.S. News at $299 a month on a 12-month plan paid upfront, $349 on six months, $369 on three months and $399 month-to-month. A fourth source states Found charges a $99 to $199 membership with medication billed separately — https://health.usnews.com/best-diet/medication/found (captured 2026-07-27, third_party)
- EV-2903: TrimRx, itself a provider, publishes that LillyDirect's Zepbound vial programme runs $399 to $549 a month, and that Zepbound's 2026 list price is $1,349 with Mounjaro at $1,135 — https://trimrx.com/blog/tirzepatide-cost-breakdown/ (captured 2026-07-27, third_party)
- EV-3001: Eden Health's compounded tirzepatide pricing changed structure during 2026. A source that verified on tryeden.com on 17 April 2026 recorded $249 for the first month then $329 a month, with an explicit 'Same Price at Every Dose' policy and no membership fees. A source reporting as of 9 July 2026 records $199 a month for the medication with a $99 ongoing membership now required, an effective $298, and states the ongoing combined cost fell from $396 to $298 — https://www.talktomira.com/post/is-eden-health-weight-loss-legit-comprehensive-reviews (captured 2026-07-27, third_party)
- EV-3002: Eden Health's own domain publishes that LillyDirect offers Zepbound single-dose vials starting at $299 a month, and that the Zepbound list price is $1,086.37 for a 28-day supply of four prefilled pens, the same whether at the 2.5 mg starter dose or the 15 mg maintenance dose — https://www.eden.health/post/zepbound-tirzepatide-cost (captured 2026-07-27, reported)
- EV-3101: Trimi's own treatment page states compounded tirzepatide starts at $125 a month, that the figure applies to the 12-month plan paid upfront or via buy-now-pay-later, that it includes the telehealth visit and free shipping, and that the cost runs $125 to $235 a month depending on billing plan — https://trytrimi.com/treatments/tirzepatide (captured 2026-07-27, verified)
- EV-3102: MEDVi and SkinnyRx, both compounded GLP-1 telehealth platforms, received FDA warning letters on 20 February 2026 over misleading marketing of compounded products, and have been removed from most current rankings. A separate source records that Skinny Rx, operated by Lean Rx Inc. of Sacramento, received an FDA warning letter on 20 February 2026 over labelling and marketing claims — https://plexusdx.com/blogs/learn/best-online-tirzepatide-provider-plexusdx (captured 2026-07-27, reported)
- EV-3103: Yucca Health is reported to advertise $258 for the first month on a six-month plan and $325 a month thereafter, with orders final sale once medication ships — https://plexusdx.com/blogs/learn/best-online-tirzepatide-provider-plexusdx (captured 2026-07-27, reported)
- EV-3104: SkinnyRx is reported by U.S. News to start at $150 a month for compounded medication with no membership fee, and its tirzepatide tablets are reported as advertised at $299 a month, verified on skinnyrx.com in April 2026 — https://health.usnews.com/best-diet/medication/skinnyrx (captured 2026-07-27, reported)
- EV-3301: The FDA approved Foundayo (orforglipron) tablets on 1 April 2026 under NDA 220934, for adults with obesity or overweight with at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity. The approval letter states the application was received 20 January 2026 and is approved effective on the date of the letter — https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220934Orig1s000ltr.pdf (captured 2026-07-27, verified)
- EV-3302: Lilly's announcement states adults taking Foundayo lost an average of 27 pounds on the highest dose in ATTAIN-1, an average of 12.4% weight loss at the highest dose, that it is available via LillyDirect with prescriptions accepted immediately and shipping from 6 April 2026, at as little as $25 a month with commercial coverage and $149 self-pay for the lowest dose, with eligible Medicare Part D individuals able to pay $50 a month from 1 July 2026 — https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill (captured 2026-07-27, verified)
- EV-3303: The Foundayo label carries a boxed warning for thyroid C-cell tumours but states that orforglipron is not pharmacologically active in rats or mice and did not produce tumours in rodents, and that while it is pharmacologically active at the human GLP-1 receptor, the human relevance of the rodent findings has not been determined. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2 — https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf (captured 2026-07-27, verified)
- EV-3304: A telehealth guide publisher stating a library of 1,452 guides published that orforglipron received a Complete Response Letter from the FDA on 10 April 2026 and is not yet available. The FDA approval letter for NDA 220934 is dated 1 April 2026 and the product has been listed on DailyMed since approval — https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220934Orig1s000ltr.pdf (captured 2026-07-27, verified)
- EV-3305: Novo Nordisk's oral semaglutide, marketed as the Wegovy pill, received FDA approval in December 2025 — https://www.ajmc.com/view/fda-approves-lilly-s-oral-glp-1-orforglipron-for-obesity (captured 2026-07-27, reported)
- EV-3401: On 9 March 2026 Novo Nordisk and Hims & Hers Health announced a settlement under which Hims will offer branded Novo Nordisk products and stop marketing compounded GLP-1 medications. Hims no longer offers tirzepatide — https://peptidesexplorer.com/blog/henry-meds-reviews (captured 2026-07-27, reported)
- EV-3402: Henry Meds compounded tirzepatide is reported at about $297 a month introductory and $429 to $549 at maintenance by one source, from $199 a month by another, and $1,047 for a three-month oral supply by Forbes Health. Henry Meds is reported to have no public FDA warning letter as of March 2026 but to face an active Eli Lilly lawsuit filed in April 2025 alleging marketing practices similar to those cited in the FDA warning letters — https://trimrx.com/blog/cheapest-compounded-tirzepatide-providers-2026/ (captured 2026-07-27, third_party)
- EV-3403: A publisher ranking tirzepatide providers discloses that its recommendations are sponsored affiliate links, and separately notes that the $179 figure it cites for one provider is for compounded semaglutide rather than tirzepatide, and that another provider's $69 oral kits contain metformin, bupropion and naltrexone rather than any GLP-1 medication — https://therxindex.com/guides/best-online-tirzepatide-providers/ (captured 2026-07-27, reported)
- EV-3501: NexLife's own plan pages name five fulfilment partners &mdash; Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy and Strive Pharmacy &mdash; and state that fulfilment may be supported by qualified 503A compounding pharmacies and FDA-registered 503B outsourcing facilities operating under cGMP, prepared under state board oversight to USP <797> sterile compounding standards — https://nexlife.us/pages/google-semaglutide-12-month-plan (captured 2026-07-27, verified)
- EV-3502: NexLife's own pages describe a Care360 model that may include ongoing provider oversight, clinical follow-up, behavioural support, patient education, nutrition guidance, metabolic health tracking and continuous care coordination, and state that patients may optionally connect health data from Apple Health, Apple Watch, Google Health Connect and Google Fit so the care team can review activity, weight trends, heart rate and nutrition — https://nexlife.us/pages/google-tirzepatide-6-month-plan (captured 2026-07-27, verified)
- EV-3503: NexLife's own pages state it is a LegitScript-certified, physician-led telehealth platform operating through affiliated physician-owned medical groups, that it works exclusively with LegitScript-certified, NABP-accredited pharmacies, that medication ships free in one to two business days, and that orders are backed by a money-back warranty — https://nexlife.us/pages/frequently-asked-questions (captured 2026-07-27, verified)
- EV-3504: NexLife's own pages state compounded semaglutide from $145 a month and compounded tirzepatide from $186 a month, with $215 a month on the monthly plan at the same price at every dose and no hidden fees — https://nexlife.us/pages/google-tirzepatide-6-month-plan (captured 2026-07-27, verified)
- EV-3505: A separate publication scores NexLife at 94 of 100 against its own six-pillar rubric. That is a different rubric from ours and we do not import scores from other publications — https://tirzepatidereview.com/providers/nexlife (captured 2026-07-27, third_party)
- EV-3601: On 24 July 2026 BBB National Programs' National Advertising Division announced that Willow Health Services, a telehealth company, had permanently discontinued advertising claims for its compounded semaglutide products after a challenge brought by Novo Nordisk. The reopened matter followed a December 2025 NAD decision and a referral to the Federal Trade Commission and state attorneys general — https://www.teleranked.com/llms.txt (captured 2026-07-27, reported)
- EV-3602: On 24 July 2026 the U.S. Attorney for the Western District of Texas announced that Total MD Physicians Group, trading as Total Men's Primary Care, and Dr Mason Jones agreed to a consent judgment requiring payment of up to $600,000 in civil penalties to resolve alleged Controlled Substances Act violations. The government alleged recordkeeping failures and the electronic signing and transmitting of prescriptions for a Schedule II controlled substance without a doctor-patient relationship. The claims are allegations only and there has been no determination of liability — https://www.teleranked.com/llms.txt (captured 2026-07-27, reported)
- EV-3603: On 8 July 2026 a federal judge sentenced Dr David Antonio Becerril of Coeur d'Alene, Idaho, to 40 months in prison and ordered more than $1.25 million in restitution after a jury convicted him of signing Medicare orders for genetic tests and orthotic braces for patients he had never examined. Prosecutors said he worked through a telemedicine company and spent about 26 seconds on each order — https://www.teleranked.com/llms.txt (captured 2026-07-27, reported)
- EV-3604: On 16 July 2026 CMS published a proposed rule for the CY2027 Medicare Physician Fee Schedule that would, if finalised, bar Medicare payment for remote physiologic and remote therapeutic monitoring delivered by outsourced third-party vendors, require those services to be furnished by a practice's own employed clinical staff, limit remote therapeutic monitoring to established patients and require a separate initiating visit. The proposal is not final and the comment period runs through 14 September 2026 — https://www.teleranked.com/llms.txt (captured 2026-07-27, reported)
- EV-3702: An estimated 24 million Americans lost commercial GLP-1 insurance coverage across 2025 and 2026, attributed to KFF and NPR reporting — https://glp1watchdog.com/ (captured 2026-07-28, third_party)
- EV-3703: Brand Ozempic is reported at a list price of $936 to $998 a month without insurance, and as low as $25 a month with commercial insurance plus a manufacturer savings card — https://glp1watchdog.com/cost/ozempic-without-insurance (captured 2026-07-28, third_party)
- EV-3801: A consumer scam-checker page lists as a red flag: semaglutide for $99 a month or less, and states that legitimate compounded semaglutide costs $150 to $400 a month, adding that if it seems too cheap, it is. The same page carries a scrolling price ticker showing Embody at $69 a month and Bodybuilding.com Health+ at $99 a month, and the same publisher's machine-readable file lists Embody as its cheapest verified provider rated 9.0 out of 10 at $69 a month — https://glp1watchdog.com/safety/scam-checker (captured 2026-07-28, verified)
- EV-3802: The same scam-checker page lists as a red flag a provider that cannot supply the name and state licence number of its dispensing pharmacy, and states that every legitimate pharmacy has a verifiable state licence — https://glp1watchdog.com/safety/scam-checker (captured 2026-07-28, verified)
- EV-4001: NexLife publishes six protocols across two molecules, each with four billing terms, all flat at every covered dose. Tirzepatide regular $215/$195/$190/$186; semaglutide regular $165/$149/$147/$145; tirzepatide microdose $189/$159/$150/$147; semaglutide microdose $129/$117/$114/$110; tirzepatide sublingual ODT $229/$219/$205/$199; semaglutide sublingual ODT $199/$185/$177/$165, by month-to-month, three, six and twelve-month terms respectively — https://nexlife.us/pages/tirzepatide-all-plans (captured 2026-07-28, verified)
- EV-4101: Public reviews of Embody dated within 48 hours report charges that do not match any advertised figure. One reviewer marked verified states paying $249 a month against advertising seen online for $119. Another reports being charged $378 before any consultation or product. A third refers to paying $129. A fourth reports being told a resend would cost over $100. Figures advertised for the same provider in comparison roundups over the same period were $99 and later $69 — https://www.trustpilot.com/review/embodyhealth.com (captured 2026-07-28, reported)
- EV-4102: The same body of reviews reports recurring operational problems: charges taken before a telehealth visit occurred, prescriptions dispensed at a lower dose than the patient's prior prescription, medication shipped to an address the patient states was incorrect and corrected in advance, hold times of 20 to 30 minutes, callbacks that did not arrive, and cancellation and refund requests left unconfirmed — https://www.trustpilot.com/review/embodyhealth.com (captured 2026-07-28, reported)
- EV-4401: Forbes Health lists Henry Meds compounded liraglutide at $179 monthly, compounded oral tirzepatide at $1,047 for a three-month supply, and compounded phentermine at $149 monthly — https://www.forbes.com/health/weight-loss/henry-meds-review/ (captured 2026-07-29, reported)
- EV-4402: A reviewer who reached checkout reports Henry Meds compounded semaglutide injection at $297 a month, dropping to $247 on a six-month plan and $197 on a twelve-month plan, with no separate membership fee, and states that pricing for compounded tirzepatide, microdose options and oral formats is hidden until the patient starts an intake quiz, with several pages requiring an appointment to see a quote at all — https://www.vaccinealliance.org/reviews/henry-meds/ (captured 2026-07-29, reported)
- EV-4403: Henry Meds holds a 4.5 of 5 Trustpilot rating across more than 11,000 reviews, an F rating from the Better Business Bureau, and Trustpilot has flagged the review page with a notice indicating suspected fraudulent reviews. The company launched in February 2022 and is operated by Adonis Health Inc. of San Francisco. It does not name its fulfilling pharmacies publicly, though the pharmacy is named on the medication label — https://peptidesexplorer.com/blog/henry-meds-reviews (captured 2026-07-29, reported)
- EV-4501: Eden's compounded tirzepatide is published at six different structures in 2026. A review dated 9 July 2026 records $199 medication plus a required $99 ongoing membership and a $39 introductory membership, an effective $298. A source that verified on tryeden.com on 17 April 2026 records $249 for the first month then $329 a month, with an explicit 'Same Price at Every Dose' policy and no membership fees. U.S. News records $199. A competitor's analysis uses $329 average, $3,948 a year. Older official campaign pages display $249 then $329 for tirzepatide, and $129 then $209 or $149 then $229 for semaglutide — https://www.tryeden.com/ (captured 2026-07-29, third_party)
- EV-4502: The same July 2026 review records that Eden's ongoing combined cost for compounded tirzepatide fell from $396 to $298, a decrease of about 25%, and that Eden's branded medication prices of $1,399 to $1,695 are medication-only and require the $99 ongoing membership on top — https://www.talktomira.com/post/is-eden-health-weight-loss-legit-comprehensive-reviews (captured 2026-07-29, third_party)